<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
	<front>
		<journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="publisher">pgen</journal-id><journal-id journal-id-type="flc">plge</journal-id><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="pmc">plosgen</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Genetics</journal-title></journal-title-group><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher>
				<publisher-name>Public Library of Science</publisher-name>
				<publisher-loc>San Francisco, USA</publisher-loc>
			</publisher></journal-meta>
		<article-meta><article-id pub-id-type="doi">10.1371/journal.pgen.0020054</article-id><article-id pub-id-type="publisher-id">05-PLGE-RA-0216R3</article-id><article-id pub-id-type="sici">plge-02-04-19</article-id><article-categories>
				<subj-group subj-group-type="heading">
					<subject>Research Article</subject>
				</subj-group>
				<subj-group subj-group-type="Discipline">
					<subject>Computational Biology</subject>
					<subject>Biotechnology</subject>
					<subject>Evolutionary Biology</subject>
					<subject>Genetics and Genomics</subject>
					<subject>Genetics and Genomics/Gene Expression</subject>
				</subj-group>
				<subj-group subj-group-type="System Taxonomy">
					<subject>Mammals</subject>
					<subject>Mus (mouse)</subject>
					<subject>Homo (human)</subject>
				</subj-group>
			</article-categories><title-group><article-title>Mice and Men: Their Promoter Properties</article-title><alt-title alt-title-type="running-head">Promoter Properties</alt-title></title-group><contrib-group>
				<contrib contrib-type="author" xlink:type="simple">
					<name name-style="western">
						<surname>Bajic</surname>
						<given-names>Vladimir B</given-names>
					</name>
					<xref ref-type="aff" rid="aff1">
						<sup>1</sup>
					</xref>
					<xref ref-type="aff" rid="aff2">
						<sup>2</sup>
					</xref>
					<xref ref-type="corresp" rid="cor1">
						<sup>*</sup>
					</xref>
				</contrib>
				<contrib contrib-type="author" xlink:type="simple">
					<name name-style="western">
						<surname>Tan</surname>
						<given-names>Sin Lam</given-names>
					</name>
					<xref ref-type="aff" rid="aff1">
						<sup>1</sup>
					</xref>
					<xref ref-type="aff" rid="aff2">
						<sup>2</sup>
					</xref>
				</contrib>
				<contrib contrib-type="author" xlink:type="simple">
					<name name-style="western">
						<surname>Christoffels</surname>
						<given-names>Alan</given-names>
					</name>
					<xref ref-type="aff" rid="aff3">
						<sup>3</sup>
					</xref>
					<xref ref-type="aff" rid="aff4">
						<sup>4</sup>
					</xref>
				</contrib>
				<contrib contrib-type="author" xlink:type="simple">
					<name name-style="western">
						<surname>Schönbach</surname>
						<given-names>Christian</given-names>
					</name>
					<xref ref-type="aff" rid="aff5">
						<sup>5</sup>
					</xref>
				</contrib>
				<contrib contrib-type="author" xlink:type="simple">
					<name name-style="western">
						<surname>Lipovich</surname>
						<given-names>Leonard</given-names>
					</name>
					<xref ref-type="aff" rid="aff6">
						<sup>6</sup>
					</xref>
				</contrib>
				<contrib contrib-type="author" xlink:type="simple">
					<name name-style="western">
						<surname>Yang</surname>
						<given-names>Liang</given-names>
					</name>
					<xref ref-type="aff" rid="aff7">
						<sup>7</sup>
					</xref>
				</contrib>
				<contrib contrib-type="author" xlink:type="simple">
					<name name-style="western">
						<surname>Hofmann</surname>
						<given-names>Oliver</given-names>
					</name>
					<xref ref-type="aff" rid="aff2">
						<sup>2</sup>
					</xref>
				</contrib>
				<contrib contrib-type="author" xlink:type="simple">
					<name name-style="western">
						<surname>Kruger</surname>
						<given-names>Adele</given-names>
					</name>
					<xref ref-type="aff" rid="aff2">
						<sup>2</sup>
					</xref>
				</contrib>
				<contrib contrib-type="author" xlink:type="simple">
					<name name-style="western">
						<surname>Hide</surname>
						<given-names>Winston</given-names>
					</name>
					<xref ref-type="aff" rid="aff2">
						<sup>2</sup>
					</xref>
				</contrib>
				<contrib contrib-type="author" xlink:type="simple">
					<name name-style="western">
						<surname>Kai</surname>
						<given-names>Chikatoshi</given-names>
					</name>
					<xref ref-type="aff" rid="aff8">
						<sup>8</sup>
					</xref>
				</contrib>
				<contrib contrib-type="author" xlink:type="simple">
					<name name-style="western">
						<surname>Kawai</surname>
						<given-names>Jun</given-names>
					</name>
					<xref ref-type="aff" rid="aff8">
						<sup>8</sup>
					</xref>
					<xref ref-type="aff" rid="aff9">
						<sup>9</sup>
					</xref>
				</contrib>
				<contrib contrib-type="author" xlink:type="simple">
					<name name-style="western">
						<surname>Hume</surname>
						<given-names>David A</given-names>
					</name>
					<xref ref-type="aff" rid="aff10">
						<sup>10</sup>
					</xref>
				</contrib>
				<contrib contrib-type="author" xlink:type="simple">
					<name name-style="western">
						<surname>Carninci</surname>
						<given-names>Piero</given-names>
					</name>
					<xref ref-type="aff" rid="aff8">
						<sup>8</sup>
					</xref>
					<xref ref-type="aff" rid="aff9">
						<sup>9</sup>
					</xref>
				</contrib>
				<contrib contrib-type="author" xlink:type="simple">
					<name name-style="western">
						<surname>Hayashizaki</surname>
						<given-names>Yoshihide</given-names>
					</name>
					<xref ref-type="aff" rid="aff8">
						<sup>8</sup>
					</xref>
					<xref ref-type="aff" rid="aff9">
						<sup>9</sup>
					</xref>
				</contrib>
			</contrib-group><aff id="aff1">
				<label>1</label>
				<addr-line> Knowledge Extraction Laboratory, Institute for Infocomm Research,
					Singapore </addr-line>
			</aff><aff id="aff2">
				<label>2</label>
				<addr-line> South African National Bioinformatics Institute, University of the
					Western Cape, Bellville, South Africa </addr-line>
			</aff><aff id="aff3">
				<label>3</label>
				<addr-line> Temasek Life Sciences Laboratory, National University of Singapore,
					Singapore </addr-line>
			</aff><aff id="aff4">
				<label>4</label>
				<addr-line> School of Biological Sciences, Nanyang Technological University,
					Singapore </addr-line>
			</aff><aff id="aff5">
				<label>5</label>
				<addr-line> Immunoinformatics Research Team, Advanced Genome Information Technology
					Research Group, RIKEN Genomic Sciences Center, RIKEN Yokohama Institute,
					Yokohama, Japan </addr-line>
			</aff><aff id="aff6">
				<label>6</label>
				<addr-line> Genome Institute of Singapore, Singapore </addr-line>
			</aff><aff id="aff7">
				<label>7</label>
				<addr-line> Department of Obstetrics and Gynecology, National University Hospital,
					National University of Singapore, Singapore </addr-line>
			</aff><aff id="aff8">
				<label>8</label>
				<addr-line> Genome Exploration Research Group (Genome Network Project Core Group),
					RIKEN Genomic Sciences Center, RIKEN Yokohama Institute, Yokohama, Japan
				</addr-line>
			</aff><aff id="aff9">
				<label>9</label>
				<addr-line> Genome Science Laboratory, Discovery Research Institute, RIKEN Wako
					Institute, Wako, Japan </addr-line>
			</aff><aff id="aff10">
				<label>10</label>
				<addr-line> Australian Research Council Special Research Centre for Functional and
					Applied Genomics, Institute for Molecular Bioscience, University of Queensland,
					Brisbane, Queensland, Australia </addr-line>
			</aff><contrib-group>
				<contrib contrib-type="editor" xlink:type="simple">
					<name name-style="western">
						<surname>Blake</surname>
						<given-names>Judith</given-names>
					</name>
					<role>Editor</role>
					<xref ref-type="aff" rid="edit1"/>
				</contrib>
				<contrib contrib-type="editor" xlink:type="simple">
					<name name-style="western">
						<surname>Hancock</surname>
						<given-names>John</given-names>
					</name>
					<role>Editor</role>
					<xref ref-type="aff" rid="edit2"/>
				</contrib>
				<contrib contrib-type="editor" xlink:type="simple">
					<name name-style="western">
						<surname>Pavan</surname>
						<given-names>Bill</given-names>
					</name>
					<role>Editor</role>
					<xref ref-type="aff" rid="edit3"/>
				</contrib>
				<contrib contrib-type="editor" xlink:type="simple">
					<name name-style="western">
						<surname>Stubbs</surname>
						<given-names>Lisa</given-names>
					</name>
					<role>Editor</role>
					<xref ref-type="aff" rid="edit4"/>
				</contrib>
				<contrib contrib-type="editor" xlink:type="simple">
					<collab xlink:type="simple"><italic>PLoS Genetics</italic> EIC Wayne
						Frankel</collab>
					<role>Editor</role>
					<xref ref-type="aff" rid="edit5"/>
				</contrib>
			</contrib-group><aff id="edit1">The Jackson Laboratory, US</aff><aff id="edit2">MRC-Harwell, UK</aff><aff id="edit3">NHGRI-NIH, US</aff><aff id="edit4">Lawrence Livermore National Laboratory, US</aff><aff id="edit5">The Jackson Laboratory, US</aff><author-notes>
				<fn fn-type="con" id="ack1">
					<p>VBB, JK, PC, and YH conceived and designed the experiments. VBB, SLT, and CK
						performed the experiments. VBB, SLT, AC, CS, LL, and OH analyzed the data.
						VBB, SLT, LY, OH, AK, WH, CK, JK, PC, and YH contributed
						reagents/materials/analysis tools. VBB, AC, CS, OH, and DAH wrote the
						paper.</p>
				</fn>
				<corresp id="cor1">* To whom correspondence should be addressed. E-mail: <email xlink:type="simple">vlad@sanbi.ac.za</email>
				</corresp>
			<fn fn-type="conflict" id="ack3">
				<p> The authors have declared that no competing interests exist.</p>
			</fn></author-notes><pub-date pub-type="ppub">
				<month>4</month>
				<year>2006</year>
			</pub-date><pub-date pub-type="epub">
				<day>28</day>
				<month>4</month>
				<year>2006</year>
			</pub-date><volume>2</volume><issue>4</issue><elocation-id>e54</elocation-id><history>
				<date date-type="received">
					<day>15</day>
					<month>8</month>
					<year>2005</year>
				</date>
				<date date-type="accepted">
					<day>27</day>
					<month>2</month>
					<year>2006</year>
				</date>
			</history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2006</copyright-year><copyright-holder>Bajic et al</copyright-holder><license><license-p>This is an open-access article distributed under the
				terms of the Creative Commons Attribution License, which permits unrestricted use,
				distribution, and reproduction in any medium, provided the original author and
				source are credited.</license-p></license></permissions><abstract>
				<p>Using the two largest collections of <named-content content-type="genus-species" xlink:type="simple">Mus musculus</named-content> and <named-content content-type="genus-species" xlink:type="simple">Homo
						sapiens</named-content> transcription start sites (TSSs) determined based on
					CAGE tags, ditags, full-length cDNAs, and other transcript data, we describe the
					compositional landscape surrounding TSSs with the aim of gaining better insight
					into the properties of mammalian promoters. We classified TSSs into four types
					based on compositional properties of regions immediately surrounding them. These
					properties highlighted distinctive features in the extended core promoters that
					helped us delineate boundaries of the transcription initiation domain space for
					both species. The TSS types were analyzed for associations with initiating
					dinucleotides, CpG islands, TATA boxes, and an extensive collection of
					statistically significant <italic>cis</italic>-elements in mouse and human. We
					found that different TSS types show preferences for different sets of initiating
					dinucleotides and <italic>cis</italic>-elements. Through Gene Ontology and eVOC
					categories and tissue expression libraries we linked TSS characteristics to
					expression. Moreover, we show a link of TSS characteristics to very specific
					genomic organization in an example of immune-response-related genes
					(GO:0006955). Our results shed light on the global properties of the two
					transcriptomes not revealed before and therefore provide the framework for
					better understanding of the transcriptional mechanisms in the two species, as
					well as a framework for development of new and more efficient promoter- and
					gene-finding tools.</p>
			</abstract><abstract abstract-type="synopsis">
				<title>Synopsis</title>
				<p>Tens of thousands of mammalian genes are expressed in various cells at different
					times, controlled mainly at the promoter level through the interaction of
					transcription factors with <italic>cis</italic>-elements. The authors analyzed
					properties of a large collection of experimental mouse <italic>(Mus
						musculus)</italic> and human <italic>(Homo sapiens)</italic> transcription
					start sites (TSSs). They defined four types of TSSs based on the compositional
					properties of surrounding regions and showed that (a) the regions surrounding
					TSSs are much richer in properties than previously thought, (b) the four TSSs
					types are associated with distinct groups of <italic>cis</italic>-elements and
					initiating dinucleotides, (c) the regions upstream of TSSs are distinctly
					different from the downstream ones in terms of the associated
						<italic>cis</italic>-elements, and (d) mouse and human TSS properties
					relative to CpG islands (CGIs) and TATA box elements suggest species-specific
					adaptation. The authors linked TSS characteristics to gene expression through
					categories defined by the Gene Ontology and eVOC classifications and tissue
					expression libraries. They provided examples of the preference of immune
					response genes for TSS types and specific genomic organization. Their results
					shed light on the fine compositional properties of TSSs in mammals and could
					lead to better design of promoter- and gene-finding tools, better annotation of
					promoters by <italic>cis</italic>-elements, and better regulatory network
					reconstructions. These areas represent some of the focal topics of
					bioinformatics and genomics research that are of interest to a wide range of
					life scientists.</p>
			</abstract><funding-group><funding-statement>This study was supported by a research grant for the RIKEN Genome Exploration
					Research Project from the Ministry of Education, Culture, Sports, Science and
					Technology of Japan to YH, a grant of the Genome Network Project from the
					Ministry of Education, Culture, Sports, Science and Technology of Japan to YH.,
					and a grant for the Strategic Programs for R&amp;D of RIKEN to YH.</funding-statement></funding-group><counts>
				<page-count count="13"/>
			</counts><!--===== Restructure custom-meta-wrap to custom-meta-group =====--><custom-meta-group>
				<custom-meta>
					<meta-name>Citation:</meta-name>
					<meta-value>Bajic VB, Tan SL, Christoffels A, Schönbach C, Lipovich L, et al.
						(2006) Mice and men: Their promoter properties. PLoS Genet 2(4): e54. DOI:
							<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pgen.0020054" xlink:type="simple">10.1371/journal.pgen.0020054</ext-link></meta-value>
				</custom-meta>
				<custom-meta>
					<meta-name>article-logo</meta-name>
					<meta-value>Fantom_Logo.jpg</meta-value>
				</custom-meta>
			</custom-meta-group></article-meta>
	</front>
	<body>
		<p>
			<graphic mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.0020054.fantom3_logo" xlink:type="simple"/>
		</p>
		<sec id="s1">
			<title>Introduction</title>
			<p>The computational identification and functional analysis of mammalian promoters has,
				to date, been constrained by the relatively small datasets of experimentally
				confirmed transcription start sites (TSSs). For example, promoters within dbTSS were
				recently updated with the mapping of 195,446 FANTOM2 mouse full-length cDNA
				sequences to 6,875 RefSeq mouse genes [<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>,<xref ref-type="bibr" rid="pgen-0020054-b002">2</xref>]. Functional
				analyses of these mammalian promoters have been restricted to shared transcription
				factor binding sites (TFBSs) between human and mouse datasets [<xref ref-type="bibr" rid="pgen-0020054-b002">2</xref>]. Using the same collection of promoters
				contained in dbTSS, Aerts et al. embarked on a characterization of promoters by
				extending their study to <named-content content-type="genus-species" xlink:type="simple">Drosophila melanogaster</named-content> and <named-content content-type="genus-species" xlink:type="simple">Fugu rubripes</named-content>
					[<xref ref-type="bibr" rid="pgen-0020054-b003">3</xref>]. Further
				characterization of mammalian promoters is dependent on the availability of
				experimentally verified TSSs that would complement and extend existing datasets
				represented by the FANTOM collection, dbTSS, the H-Invitational database [<xref ref-type="bibr" rid="pgen-0020054-b004">4</xref>], and RefSeq. The latest effort
				of the FANTOM3 consortium [<xref ref-type="bibr" rid="pgen-0020054-b005">5</xref>]
				has provided the scientific community with the largest collection of transcriptome
				data for <named-content content-type="genus-species" xlink:type="simple">Mus
					musculus</named-content> (mouse), and has complemented this with CAGE tags of
					<named-content content-type="genus-species" xlink:type="simple">Homo
					sapiens</named-content> (human). Based on these data we provide a comprehensive
				comparative analysis of mouse and human promoters that results in a number of new
				insights that help us to better understand the transcriptional scenario in these two
				species.</p>
			<p>GC properties are well-known global factors that influence promoter characteristics
				and gene expression [<xref ref-type="bibr" rid="pgen-0020054-b003">3</xref>,<xref ref-type="bibr" rid="pgen-0020054-b006">6</xref>–<xref ref-type="bibr" rid="pgen-0020054-b009">9</xref>]. In addition, GC characteristics influence
				important DNA properties such as the “bendability” and curvature of the DNA helix
				and consequently influence the interplay of DNA and chromatin, which impacts
				transcription. We set out to characterize the regions immediately surrounding TSSs
				based on such compositional properties. Our determination of tentative TSS locations
				has been based on the use of CAGE tags [<xref ref-type="bibr" rid="pgen-0020054-b010">10</xref>] and ditags [<xref ref-type="bibr" rid="pgen-0020054-b011">11</xref>] enriched with additional independent pieces
				of evidence of transcript existence including 5′ expressed sequence tags, long
				5′-SAGE, and the 5′ ends of fully sequenced cDNAs from full-length libraries.</p>
			<p>In this study, we report several distinctive features in the extended core promoters
				that helped us delineate the boundaries of the transcription initiation domain space
				for both mouse and human, as well as delineate species-specific characteristics
				within that space. We describe the association of TSS types with the initiating
				dinucleotide, CGIs, TATA boxes, and an extensive collection of statistically
				significant <italic>cis</italic>-elements in mouse and human, and correlate TSS
				properties with expression data through comparison with Gene Ontology (GO) [<xref ref-type="bibr" rid="pgen-0020054-b012">12</xref>] and eVOC [<xref ref-type="bibr" rid="pgen-0020054-b013">13</xref>] categories, tissue expression
				libraries, and specific genome organization.</p>
		</sec>
		<sec id="s2">
			<title>Results/Discussion</title>
			<sec id="s2a">
				<title>GC Content and TSS Types</title>
				<p>We considered TSS properties based on the GC characteristics of the segments
					immediately upstream and downstream of experimentally estimated TSSs. We split
					TSSs into four distinct classes based on the GC content upstream and downstream
					of the TSS, as shown in <xref ref-type="table" rid="pgen-0020054-t001">Table
						1</xref> (see <xref ref-type="sec" rid="s3">Materials and Methods</xref>).
					These four tentative TSS types have been used as a tool to investigate different
					promoter features in mouse and human. Two TSS types do not differ in GC richness
					between the upstream and downstream regions. They are GC-rich (GC-GC, type A) or
					AT-rich (AT-AT, type D) both upstream and downstream. The other two are GC-rich
					upstream and AT-rich downstream (GC-AT, type B) and, vice versa, AT-rich
					upstream and GC-rich downstream (AT-GC, type C). The distributions of TSS
					positions in the case of mouse and human are depicted in <xref ref-type="fig" rid="pgen-0020054-g001">Figure 1</xref>. A strong polarization of the TSS
					distribution exists, with TSS types A and D being most prevalent (<xref ref-type="fig" rid="pgen-0020054-g001">Figure 1</xref>A). The number of TSSs
					in each of the TSS types remains almost unchanged if the length of the upstream
					and downstream regions changes (<xref ref-type="supplementary-material" rid="pgen-0020054-sg001">Figure S1</xref>); it also only gradually changes
					with a change of threshold for GC richness (<xref ref-type="supplementary-material" rid="pgen-0020054-sg001">Figure
					S1</xref>). These findings suggest robustness of our TSS classification.</p>
				<table-wrap content-type="1col" id="pgen-0020054-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.0020054.t001</object-id><label>Table 1</label><caption>
						<p>Four TSS Types Defined Based on the GC Content Upstream and Downstream of
							the TSS</p>
					</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.t001" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb1col1" align="left" charoff="0" char=""/><col id="tb1col2" align="left" charoff="0" char=""/><col id="tb1col3" align="left" charoff="0" char=""/></colgroup><thead><tr><td align="left"><hr/>TSS Type</td><td><hr/>Upstream GC Content</td><td><hr/>Downstream GC Content</td></tr></thead><tbody><tr><td>A</td><td>GC-rich</td><td>GC-rich</td></tr><tr><td>B</td><td>GC-rich</td><td>AT-rich</td></tr><tr><td>C</td><td>AT-rich</td><td>GC-rich</td></tr><tr><td>D</td><td>AT-rich</td><td>AT-rich</td></tr></tbody></table> --><!-- <table-wrap-foot><fn id="nt101"><p>GC-rich means G &plus; C &gt; 50&percnt; in the considered region. AT-rich (i.e., GC-poor) means G &plus; C &le; 50&percnt; in the considered region. In our case, the upstream region is &lsqb;&minus;100, &minus;1&rsqb;, and the downstream region is &lsqb;&plus;1, &plus;100&rsqb; relative to the TSS.</p></fn></table-wrap-foot> --></table-wrap>
				<fig id="pgen-0020054-g001" position="float">
					<object-id pub-id-type="doi">10.1371/journal.pgen.0020054.g001</object-id>
					<label>Figure 1</label>
					<caption>
						<title>Transcription Initiation Domains for Mouse and Human</title>
						<p>Distribution of mouse (red) TSSs overlapped by human (blue) TSSs based on
							(A) C + G content, (B) A + G content, and (C) T + G content. Nucleotide
							content is determined for upstream [−100, −1] and downstream [+1, +100]
							regions relative to the TSS. The distribution of TSS locations is more
							or less random when viewed in terms of A + G content (B) or T + G
							content (C). Strong polarization of distributions is evident only in the
							G + C case (A).</p>
					</caption>
					<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.g001" xlink:type="simple"/>
				</fig>
			</sec>
			<sec id="s2b">
				<title>Are Two TSS Types (GC-Rich and AT-Rich) Sufficient to Consider?</title>
				<p>Promoters are usually classified as either GC-rich or AT-rich, without separating
					such properties into upstream and downstream characteristics relative to the TSS
						[<xref ref-type="bibr" rid="pgen-0020054-b003">3</xref>]. In our study we
					observed that many of the TSSs that are not evidently GC-rich (both upstream and
					downstream of the TSS) have changing GC content when going from upstream to
					downstream regions (<xref ref-type="fig" rid="pgen-0020054-g002">Figure
					2</xref>). The types of patterns were AT→GC, AT→AT, and GC→AT, containing 1,911,
					1,528, and 1,440 instances, respectively, in our mouse TSS dataset. We found it
					reasonable to assign the TSSs with a change of GC content around the TSS (AT→GC
					and GC→AT) to different classes because they represent about 2/3 of all
					non-GC-GC types. We use this profiling of TSS characteristics as a
					methodological convenience. However, the biological justification for this
					relies on the fact that many <italic>cis</italic>-elements have a preference for
					GC-rich or AT-rich domains, as found in studies of promoter groups [<xref ref-type="bibr" rid="pgen-0020054-b014">14</xref>,<xref ref-type="bibr" rid="pgen-0020054-b015">15</xref>]. Thus, considering separately the GC-rich
					(AT-rich) upstream and downstream segments around TSSs provides an opportunity
					to analyze different groups of binding sites that may confer different
					transcription initiation scenarios.</p>
				<fig id="pgen-0020054-g002" position="float">
					<object-id pub-id-type="doi">10.1371/journal.pgen.0020054.g002</object-id>
					<label>Figure 2</label>
					<caption>
						<title>Distribution of Mononucleotides in Mouse Promoters in the Region
							Surrounding the TSS</title>
						<p>The nucleotides adenine, cytosine, guanine, and thymine are represented
							by blue, green, red, and light blue, respectively. The TSS types that
							are GC-poor upstream (C and D) show very characteristic enrichment in
							adenine and thymine nucleotides around [−35, −20], suggesting a
							potential dominant influence of TATA box and similar AT-rich elements in
							transcription initiation in these types. In type B and A TSSs, this
							influence does not seem to be dominant, but the presence of such
							elements is suggested by a significant reduction of the GC content in
							the [−35, −20] region. In principle, one could attempt to link the types
							of AT-rich upstream elements with initiating dinucleotides
							characteristic of different TSS types.</p>
					</caption>
					<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.g002" xlink:type="simple"/>
				</fig>
				<p>An essential support for the biological relevance of our introduced TSS
					classification relies on the fact that some eukaryotic genomes have dominant TSS
					characteristics of the classes we defined. For example, based on the work of
					Aerts et al. [<xref ref-type="bibr" rid="pgen-0020054-b003">3</xref>], TSS types
					B and C appear prevalent in <named-content content-type="genus-species" xlink:type="simple">F. rubripes</named-content> and type D in <italic>D.
						melanogaster,</italic> while type A is characteristic of the human genome.
					There are other ways to classify promoters using certain functional rather than
					compositional properties. Kadonaga [<xref ref-type="bibr" rid="pgen-0020054-b016">16</xref>] used the presence of functional core
					promoter elements (PEs) such as TATA boxes, initiators, and downstream promoter
					elements (DPEs) to classify promoters into several types. A different approach
					was used by Kim et al. [<xref ref-type="bibr" rid="pgen-0020054-b017">17</xref>]: the properties of preinitiation complex binding to promoter and the
					observed transcript expression state were used to define four promoter
					groups.</p>
				<p>We found through several sources of evidence that expanding a crude
					classification of GC-rich and AT-rich TSSs by two additional subclasses makes
					biological sense and presents certain fine details more explicitly than is
					possible if all TSSs are lumped into only two (GC-rich and AT-rich) classes.
					Very obvious examples of such details, in addition to largely different
					compositions of the putative <italic>cis</italic>-elements that reside in the
					upstream and downstream regions, are (a) specialized, but different, initiating
					dinucleotides overrepresented in a statistically significant manner in TSSs of
					different types, (b) clear differences in the surrounding environment of the
					initiating dinucleotides between the four TSS types, and (c) different
					preferences of some functional gene groups for particular TSS types. These
					features cannot be observed if the groups are lumped.</p>
			</sec>
			<sec id="s2c">
				<title>GC Content of TSS Surroundings Reflects Types of Putative
						<italic>cis</italic>-Elements</title>
				<p>By considering the GC content upstream and downstream separately, we allowed for
					one more degree of freedom in observing global TSS properties. Here we denote a
					PE as a TFBS and the strand where it is found. Many PEs have preferences for
					either GC-rich or GC-poor regions [<xref ref-type="bibr" rid="pgen-0020054-b014">14</xref>,<xref ref-type="bibr" rid="pgen-0020054-b015">15</xref>]. For
					example, the well-known TATA box element, being AT-rich, will be found more
					frequently in AT-rich regions, while the Sp1-binding sites, being GC-rich, will
					be found more frequently in GC-rich regions. Thus, the four TSS types that we
					consider could be correlated in a global manner with the potential PEs that may
					control the respective genes. Support for the influence of potential PEs on
					specific TSS types is obtained from the distributions of PE densities (<xref ref-type="fig" rid="pgen-0020054-g003">Figure 3</xref>). Density
					distributions of selected PEs that prefer GC-rich (AT-rich) domains in type B
					and type C TSSs are depicted in <xref ref-type="fig" rid="pgen-0020054-g003">Figure 3</xref>A. We observe that PE groups change their concentrations
					significantly in transition from upstream to downstream regions. Moreover, in
						<xref ref-type="fig" rid="pgen-0020054-g003">Figure 3</xref>B we present
					distributions for selected PEs across all four TSS types. The first five PEs in
						<xref ref-type="fig" rid="pgen-0020054-g003">Figure 3</xref>B (+ZF5, −AP-2,
					−Churchill, −EGR, and −PCF2) are those that prefer GC-rich regions (the plus and
					minus signs in front of the TFBS symbols denotes the strand where the TFBS is
					found). It is interesting to observe that these PEs occur in high concentrations
					in the type A group (GC-GC), occur in considerably lower concentrations in type
					D (AT-AT), and follow the change of GC content in types B and C. We observe the
					converse for the remaining seven PEs, which prefer AT-rich regions. These
					properties suggest that the four TSS types selectively associate with different
					groups of PEs.</p>
				<fig id="pgen-0020054-g003" position="float">
					<object-id pub-id-type="doi">10.1371/journal.pgen.0020054.g003</object-id>
					<label>Figure 3</label>
					<caption>
						<title>Distribution of Densities of Selected PEs in Promoters of the Four
							TSS Types in Mouse</title>
						<p>The density of PEs is calculated from the region covering [−100, +100]
							relative to the TSS. Density is determined for bins of length 50 bp and
							shifted by 10 bp. In total, there are 17 bins. The vertical axis shows
							the percentage of TSSs of the considered type that contain the PE.</p>
						<p>(A) Distribution of selected PEs that prefer GC-rich (left) and AT-rich
							(right) domains in type B (above) and type C (below) TSS groups. Bin
							number 9 is centered around the TSS. It can be seen that groups of PEs
							change significantly in their concentrations in transition from upstream
							to downstream regions and characterize two distinct TSS types (B and
							C).</p>
						<p>(B) Distribution of selected PEs across all four TSS types. Blue, green,
							red, and light blue correspond to distributions characterized by type A,
							B, C, and D TSSs. The first five PEs are those that prefer GC-rich
							regions, and the last seven PEs prefer AT-rich regions (the plus or
							minus sign in front of the TFBS symbol denotes the strand where the TFBS
							is found).</p>
					</caption>
					<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.g003" xlink:type="simple"/>
				</fig>
			</sec>
			<sec id="s2d">
				<title>Upstream and Downstream Regions Are Different: Enrichment by Specific
					PEs</title>
				<p>We analyzed the preference of upstream and downstream regions in the four TSS
					types for significantly enriched (at least 3-fold) PEs in one region as opposed
					to the other region. The results are presented in <xref ref-type="fig" rid="pgen-0020054-g004">Figure 4</xref>. To our surprise, we found that for
					all TSS types the number of enriched PEs in the upstream region is much higher
					than in the downstream region. In three types (A, C, and D) the number of PEs in
					the downstream region is minimal compared to the upstream region. The only
					exception is type B, for which there are a significant number of enriched PEs in
					the downstream region. The data suggest for type A TSSs a high influence of PEs
					that reside upstream and prefer GC-rich domains, while for type C TSSs such
					influence is likely through PEs that are located upstream of the TSS but prefer
					AT-rich domains. Contrary to these patterns, promoters with type B TSSs seem to
					utilize a mix of both GC-rich-preferring and AT-rich-preferring PEs. A
					conclusion cannot be made for type D TSSs because of the very small number of
					highly enriched elements overall. Moreover, applying the Chi-square test for the
					equality of distributions in the upstream and downstream regions we get
						<italic>p</italic> = 1.34 × 10<sup>−07</sup>, which strongly rejects the
					null hypothesis that these distributions are the same. All these findings
					suggest that upstream and downstream regions should be considered separately (as
					we do). The results emphasize enrichment of different PE groups associated with
					upstream and downstream regions in the promoters of the four TSS types.</p>
				<fig id="pgen-0020054-g004" position="float">
					<object-id pub-id-type="doi">10.1371/journal.pgen.0020054.g004</object-id>
					<label>Figure 4</label>
					<caption>
						<title>Distribution of Selected Groups of PEs That Are Highly Enriched (at
							Least 3-Fold) Upstream or Downstream of the TSS</title>
						<p>The upstream region considered covers [−100, −1], while the downstream
							region covers [+1, +100] relative to the TSS. In all TSS types, the
							upstream region contains significantly more enriched PEs than the
							downstream region.</p>
					</caption>
					<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.g004" xlink:type="simple"/>
				</fig>
			</sec>
			<sec id="s2e">
				<title>Four TSS Types Associate with Different Sets of PEs</title>
				<p>Different compositional properties of the four TSS types suggest that the TSSs
					may be controlled by specialized collections of transcription factors (TFs).
					Thus, we attempted to find the potential TFs that could play dominant roles in
					the four TSS types by identifying (a) the specificity of the top-ranked PEs
					(relative to overrepresentation index [ORI]; see <xref ref-type="sec" rid="s3">Materials and Methods</xref>) in different TSS types, (b) unique and common
					motifs in the GC-rich/AT-rich upstream/downstream regions for different TSS
					types, and (c) the most significant PEs/TFs upstream/downstream of TSSs of types
					A, B, C, and D.</p>
				<p>To carry out these analyses we initially compared the incidence of predicted
					DNA-binding sites of known TFs in the different promoter segments in mouse in
					the four TSS types against those in random mouse DNA. For the top 150 predicted
					motifs (representing approximately 10% of all elements found in these
					comparisons) determined based on ORI [<xref ref-type="bibr" rid="pgen-0020054-b015">15</xref>], we calculated Bonferroni corrected
						<italic>p</italic>-values for enrichment in the considered promoter
					segments. In the selection of these top 10% of motifs we required that they be
					present in at least 10% of the promoters in the target groups and that they have
					an ORI value not less than 1.5. In these comparisons we found that the corrected
						<italic>p</italic>-value was below the threshold of 0.05 for the great
					majority of cases. These comparisons indicate that most of the motifs for the
					considered TSS types are highly specific relative to random DNA (<xref ref-type="supplementary-material" rid="pgen-0020054-st001">Table
					S1</xref>).</p>
				<p>Next we aimed to see if promoter segments with the same GC richness share the
					same set of PEs. We compared the upstream regions of groups A versus B and C
					versus D, and the downstream regions of groups A versus C and groups B versus D.
					It is interesting to note that the upstream (GC-rich) regions of type A and B
					TSSs do share, as expected, a subset of predicted motifs, but each type is
					characterized also by a specialized collection of putative binding sites that do
					not appear in the top 150 ranked sites of the other type (for example, ETS
					appears in promoters of type B TSSs, but not in promoters of type A TSSs) (<xref ref-type="supplementary-material" rid="pgen-0020054-st002">Table
					S2</xref>).</p>
				<p>Even those TFs that are found to be common in the upstream parts of both type A
					and type B TSSs appear in significantly different proportions of promoters of
					these types, as summarized in <xref ref-type="supplementary-material" rid="pgen-0020054-sg002">Figure S2</xref>. For example, Ets (<xref ref-type="supplementary-material" rid="pgen-0020054-st001">Table S1</xref>)
					appears in AT-rich downstream segments (types B and D). However, in type B TSSs
					it appears in 17.08% of promoters, but only on the minus strand, while in type D
					it appears in 13.48% of promoters, but only on the plus strand.</p>
				<p>Moreover, if we consider unique motifs that appear in different groups, they are
					commonly present in large proportions of promoters of those target groups. For
					example, in transcripts initiated from type D TSSs, we find only two unique PEs
					in the downstream region. One is DBP, a transcriptional activator in hepatic
					cells [<xref ref-type="bibr" rid="pgen-0020054-b018">18</xref>] and member of
					the C/EBP family, which appears in 26.77% of promoters with type D TSSs and only
					on the minus strand. The other element, Ncx, is enteric neuron homeobox and acts
					as an activator [<xref ref-type="bibr" rid="pgen-0020054-b019">19</xref>] that
					is required for proper positional specification, differentiative cell fate, and
					maintenance of proper function of enteric neurons [<xref ref-type="bibr" rid="pgen-0020054-b020">20</xref>,<xref ref-type="bibr" rid="pgen-0020054-b021">21</xref>]. It is present in 41.75% of promoters
					with type D TSSs and only on the plus strand.</p>
				<p>Since any two of the four TSS types could differ in their GC content in the
					upstream, downstream, or both regions, and consequently harbor different sets of
					significant motifs, we conclude that, overall, TSS types contain sets of
					significant signature motifs (denoted by a plus sign next to the ORI value in
						<xref ref-type="supplementary-material" rid="pgen-0020054-st001">Table
						S1</xref> and a plus sign in <xref ref-type="supplementary-material" rid="pgen-0020054-st002">Table S2</xref>) that potentially may contribute to
					orientation, and are likely to interact with distinct set of TFs. This concurs
					with the results of the preceding two subsections and suggests overall different
					transcriptional programs present in the transcripts of these TSS types. Lists of
					the most significant PEs that appear in the TSS groups are provided in <xref ref-type="supplementary-material" rid="pgen-0020054-st003">Table
					S3</xref>.</p>
			</sec>
			<sec id="s2f">
				<title>The Initiating Dinucleotide and Its Environment</title>
				<p>We analyzed in mouse and human datasets the initiating dinucleotide, that is, the
					one that occupies positions [−1, +1] relative to the TSS. We found that a number
					of different initiating dinucleotides are statistically significant across
					various TSS types and that they show certain regularities related to the GC
					content of upstream and downstream regions surrounding the TSS. <xref ref-type="table" rid="pgen-0020054-t002">Table 2</xref> shows for mouse and
					human data all statistically significant cases based on the
					<italic>p</italic>-value obtained by the right-sided Fisher's exact test and
					corrected for multiplicity testing by the Bonferroni method. The association of
					initiating dinucleotide to TSS properties is very specific. It is interesting to
					note that the initiating dinucleotide TA is significantly enriched in TSS types
					that are AT-rich upstream, downstream, or both (B, C, and D), while
					dinucleotides that start with guanine (GA or GG) are significantly enriched in
					TSS types that are AT-rich specifically downstream (B and D). Type A TSSs are
					significantly enriched for dinucleotides that start with cytosine (CC, CG, and
					CT). However, the canonical initiating dinucleotide CA appears statistically
					significant only for TSS types that change GC richness (B and C). Finally, the
					TSS type C group contains AG and TG dinucleotides at a statistically significant
					level, while these do not appear significant in any other TSS type.</p>
				<table-wrap content-type="1col" id="pgen-0020054-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.0020054.t002</object-id><label>Table 2</label><caption>
						<p>Starting Dinucleotide [−1, +1] for Various TSS Types in Mouse and Human
							Datasets</p>
					</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.t002" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb2col1" align="left" charoff="0" char=""/><col id="tb2col2" align="left" charoff="0" char=""/><col id="tb2col3" align="left" charoff="0" char=""/><col id="tb2col4" align="char" charoff="0" char="."/><col id="tb2col5" align="char" charoff="0" char="."/><col id="tb2col6" align="char" charoff="0" char="."/><col id="tb2col7" align="char" charoff="0" char="."/><col id="tb2col8" align="char" charoff="0" char="."/><col id="tb2col9" align="char" charoff="0" char="."/><col id="tb2col10" align="char" charoff="0" char="."/></colgroup><thead><tr><td align="left"><hr/>Organism</td><td><hr/>Starting Dinucleotide</td><td><hr/>TSS Type</td><td><hr/>Number of Cases</td><td><hr/>Number of TSSs with Starting Dinucleotide</td><td><hr/>Total Number of TSSs in the Same TSS Group</td><td><hr/>Total Number of TSSs</td><td><hr/>Multiplicity Correction Factor</td><td><hr/><italic>p</italic>-Value</td><td><hr/>Bonferroni Corrected <italic>p</italic>-Value</td></tr></thead><tbody><tr><td>Mouse</td><td valign="bottom">AG</td><td valign="bottom">C</td><td valign="bottom">172</td><td valign="bottom">1,943</td><td valign="bottom">2,524</td><td valign="bottom">39,156</td><td valign="bottom">16</td><td valign="bottom">1.41 &times; 10<sup>&minus;5</sup></td><td valign="bottom">2.25 &times; 10<sup>&minus;4</sup></td></tr><tr><td></td><td valign="bottom">CA</td><td valign="bottom">B</td><td valign="bottom">458</td><td valign="bottom">1,440</td><td valign="bottom">10,000</td><td valign="bottom">39,156</td><td valign="bottom">16</td><td valign="bottom">3.25 &times; 10<sup>&minus;8</sup></td><td valign="bottom">5.20 &times; 10<sup>&minus;7</sup></td></tr><tr><td></td><td valign="bottom">CA</td><td valign="bottom">C</td><td valign="bottom">558</td><td valign="bottom">1,943</td><td valign="bottom">10,000</td><td valign="bottom">39,156</td><td valign="bottom">16</td><td valign="bottom">6.09 &times; 10<sup>&minus;4</sup></td><td valign="bottom">9.75 &times; 10<sup>&minus;3</sup></td></tr><tr><td></td><td valign="bottom">CC</td><td valign="bottom">A</td><td valign="bottom">1,299</td><td valign="bottom">34,245</td><td valign="bottom">1,410</td><td valign="bottom">39,156</td><td valign="bottom">16</td><td valign="bottom">7.17 &times; 10<sup>&minus;9</sup></td><td valign="bottom">1.15 &times; 10<sup>&minus;7</sup></td></tr><tr><td></td><td valign="bottom">CG</td><td valign="bottom">A</td><td valign="bottom">8,669</td><td valign="bottom">34,245</td><td valign="bottom">9,076</td><td valign="bottom">39,156</td><td valign="bottom">16</td><td valign="bottom">1.06 &times; 10<sup>&minus;185</sup></td><td valign="bottom">1.69 &times; 10<sup>&minus;184</sup></td></tr><tr><td></td><td valign="bottom">CT</td><td valign="bottom">A</td><td valign="bottom">579</td><td valign="bottom">34,245</td><td valign="bottom">635</td><td valign="bottom">39,156</td><td valign="bottom">16</td><td valign="bottom">1.80 &times; 10<sup>&minus;3</sup></td><td valign="bottom">2.88 &times; 10<sup>&minus;2</sup></td></tr><tr><td></td><td valign="bottom">GA</td><td valign="bottom">B</td><td valign="bottom">16</td><td valign="bottom">1,440</td><td valign="bottom">171</td><td valign="bottom">39,156</td><td valign="bottom">16</td><td valign="bottom">6.09 &times; 10<sup>&minus;4</sup></td><td valign="bottom">9.75 &times; 10<sup>&minus;3</sup></td></tr><tr><td></td><td valign="bottom">GA</td><td valign="bottom">D</td><td valign="bottom">15</td><td valign="bottom">1,528</td><td valign="bottom">171</td><td valign="bottom">39,156</td><td valign="bottom">16</td><td valign="bottom">2.99 &times; 10<sup>&minus;3</sup></td><td valign="bottom">4.79 &times; 10<sup>&minus;2</sup></td></tr><tr><td></td><td valign="bottom">GG</td><td valign="bottom">B</td><td valign="bottom">264</td><td valign="bottom">1,440</td><td valign="bottom">2,952</td><td valign="bottom">39,156</td><td valign="bottom">16</td><td valign="bottom">1.32 &times; 10<sup>&minus;42</sup></td><td valign="bottom">2.12 &times; 10<sup>&minus;41</sup></td></tr><tr><td></td><td valign="bottom">GG</td><td valign="bottom">D</td><td valign="bottom">350</td><td valign="bottom">1,528</td><td valign="bottom">2,952</td><td valign="bottom">39,156</td><td valign="bottom">16</td><td valign="bottom">8.28 &times; 10<sup>&minus;83</sup></td><td valign="bottom">1.33 &times; 10<sup>&minus;81</sup></td></tr><tr><td></td><td valign="bottom">TA</td><td valign="bottom">B</td><td valign="bottom">151</td><td valign="bottom">1,440</td><td valign="bottom">2,703</td><td valign="bottom">39,156</td><td valign="bottom">16</td><td valign="bottom">1.86 &times; 10<sup>&minus;7</sup></td><td valign="bottom">2.97 &times; 10<sup>&minus;6</sup></td></tr><tr><td></td><td valign="bottom">TA</td><td valign="bottom">C</td><td valign="bottom">187</td><td valign="bottom">1,943</td><td valign="bottom">2,703</td><td valign="bottom">39,156</td><td valign="bottom">16</td><td valign="bottom">2.30 &times; 10<sup>&minus;6</sup></td><td valign="bottom">3.68 &times; 10<sup>&minus;5</sup></td></tr><tr><td></td><td valign="bottom">TA</td><td valign="bottom">D</td><td valign="bottom">169</td><td valign="bottom">1,528</td><td valign="bottom">2,703</td><td valign="bottom">39,156</td><td valign="bottom">16</td><td valign="bottom">7.82 &times; 10<sup>&minus;10</sup></td><td valign="bottom">1.25 &times; 10<sup>&minus;8</sup></td></tr><tr><td></td><td valign="bottom">TG</td><td valign="bottom">C</td><td valign="bottom">455</td><td valign="bottom">1,943</td><td valign="bottom">7,381</td><td valign="bottom">39,156</td><td valign="bottom">16</td><td valign="bottom">1.55 &times; 10<sup>&minus;7</sup></td><td valign="bottom">2.48 &times; 10<sup>&minus;6</sup></td></tr><tr><td>Human</td><td valign="bottom">AA</td><td valign="bottom">D</td><td valign="bottom">12</td><td valign="bottom">385</td><td valign="bottom">88</td><td valign="bottom">10,255</td><td valign="bottom">16</td><td valign="bottom">1.03 &times; 10<sup>&minus;4</sup></td><td valign="bottom">1.65 &times; 10<sup>&minus;3</sup></td></tr><tr><td></td><td valign="bottom">CG</td><td valign="bottom">A</td><td valign="bottom">2,777</td><td valign="bottom">9,269</td><td valign="bottom">2,878</td><td valign="bottom">10,255</td><td valign="bottom">16</td><td valign="bottom">2.37 &times; 10<sup>&minus;46</sup></td><td valign="bottom">3.79 &times; 10<sup>&minus;45</sup></td></tr><tr><td></td><td valign="bottom">GG</td><td valign="bottom">D</td><td valign="bottom">85</td><td valign="bottom">385</td><td valign="bottom">578</td><td valign="bottom">10,255</td><td valign="bottom">16</td><td valign="bottom">4.28 &times; 10<sup>&minus;29</sup></td><td valign="bottom">6.85 &times; 10<sup>&minus;28</sup></td></tr><tr><td></td><td valign="bottom">TA</td><td valign="bottom">B</td><td valign="bottom">25</td><td valign="bottom">244</td><td valign="bottom">575</td><td valign="bottom">10,255</td><td valign="bottom">16</td><td valign="bottom">2.55 &times; 10<sup>&minus;3</sup></td><td valign="bottom">4.07 &times; 10<sup>&minus;2</sup></td></tr><tr><td></td><td valign="bottom">TA</td><td valign="bottom">C</td><td valign="bottom">35</td><td valign="bottom">357</td><td valign="bottom">575</td><td valign="bottom">10,255</td><td valign="bottom">16</td><td valign="bottom">8.68 &times; 10<sup>&minus;4</sup></td><td valign="bottom">1.39 &times; 10<sup>&minus;2</sup></td></tr></tbody></table> --><!-- <table-wrap-foot><fn id="nt201"><p>We show only statistically significant cases.</p></fn></table-wrap-foot> --></table-wrap>
				<p>This compositional property of the initiating dinucleotide being linked in a
					statistically significant manner to the GC properties of the upstream and
					downstream regions would not be detectable if the TSS groups were lumped. We see
					that these properties characterize significant numbers of TSSs in our mouse
					dataset, namely, 10,547 (30.80%), 889 (61.74%), 1,372 (70.61%), and 534 (34.95%)
					of TSSs of type A, B, C, and D, respectively, and thus they do not appear to be
					artifacts of the proposed TSS classification that we have introduced. The
					conclusion is that the initiating dinucleotides show specific preferences at
					statistically significant levels to different TSS environments and that a
					significant portion of TSSs in our datasets are characterized by these
					initiating dinucleotides. Moreover, almost all of them are different from the
					canonical CA dinucleotide.</p>
				<p>This last observation leads us to hypothesize that different TSS types may be
					controlled by different initiator (Inr) elements. <xref ref-type="fig" rid="pgen-0020054-g002">Figure 2</xref> depicts the quite different
					composition of the regions immediately surrounding tentative TSSs. The Inr
					elements—if they appear biologically relevant for these groups—should overlap
					TSSs and may be qualitatively different for different TSS types. Different
					initiating dinucleotides of highly statistically significant enrichment support
					such a hypothesis, and, at the same time, the variability of the observed
					initiating dinucleotides could explain the nonspecific consensus of the octamer
					Inr element [<xref ref-type="bibr" rid="pgen-0020054-b022">22</xref>]. We have
					generated sequence logos of the TSS surroundings [−5, +5] in both mouse and
					human, and present them in <xref ref-type="fig" rid="pgen-0020054-g005">Figure
						5</xref>A. We observe that the nucleotide distributions for type A (GC-GC)
					TSSs are about the same in mouse and human. However, for TSS types B, C, and D,
					there is evident difference in these distributions in the region surrounding the
					TSS, which does not contradict our hypothesis of potentially different Inr
					elements for different TSS types. <xref ref-type="fig" rid="pgen-0020054-g005">Figure 5</xref>B shows logos of regions [−35, +20] for the four TSS types
					in mouse and human. Again, we observe significant similarity between the species
					in the composition of the region for type A TSSs, while the other TSS types show
					significantly more variability. This may suggest species-specific organization
					of the core promoters for these minority TSS types (B, C, and D).</p>
				<fig id="pgen-0020054-g005" position="float">
					<object-id pub-id-type="doi">10.1371/journal.pgen.0020054.g005</object-id>
					<label>Figure 5</label>
					<caption>
						<title>Sequence Logos</title>
						<p>(A) Sequence logos for Inr in human (left) and mouse (right) obtained
							using [−5, +5] segments relative to TSS locations. There is an evident
							bias in the nucleotide composition surrounding the TSS that effectively
							determines different Inr elements.</p>
						<p>(B) Sequence logos for segments [−35, +20] relative to TSS locations.
							Strong similarity exists between human (left) and mouse (right) in TSS
							type A, while that similarity is considerably reduced for the other TSS
							types.</p>
					</caption>
					<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.g005" xlink:type="simple"/>
				</fig>
			</sec>
			<sec id="s2g">
				<title>Relation of TSS Types to TATA Box Elements and CpG Islands</title>
				<p>We analyzed the four TSS types in mouse and in human (<xref ref-type="table" rid="pgen-0020054-t003">Tables 3</xref> and <xref ref-type="table" rid="pgen-0020054-t004">4</xref>) for the presence of TATA box elements and
					association with CGIs. Globally, there are similarities in these properties of
					TSS types between these two species, but there are also significant differences.
					This mouse–human comparison must be treated with some caution, since the mouse
					and human datasets are based upon analysis of distinct tissues, and the human
					set is probably less comprehensive. In some measure, the distinctions may also
					relate to depth of coverage in the two species. However, since we considered a
					statistically large number of well-defined TSS locations in mouse (39,156) and
					in human (10,255), this makes comparison between the two species feasible.</p>
				<table-wrap content-type="1col" id="pgen-0020054-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.0020054.t003</object-id><label>Table 3</label><caption>
						<p>Basic Statistics on Relation of TATA Box Motifs, CGIs, and Four TSS Types
							for MM5 Transcripts</p>
					</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.t003" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb3col1" align="left" charoff="0" char=""/><col id="tb3col2" align="left" charoff="0" char=""/><col id="tb3col3" align="left" charoff="0" char=""/><col id="tb3col4" align="left" charoff="0" char=""/><col id="tb3col5" align="left" charoff="0" char=""/><col id="tb3col6" align="left" charoff="0" char=""/></colgroup><thead><tr><td align="left" rowspan="2"><hr/>Category</td><td colspan="5"><hr/>TSS Type</td></tr><tr><td><hr/>Type A</td><td><hr/>Type B</td><td><hr/>Type C</td><td><hr/>Type D</td><td><hr/>Overall</td></tr></thead><tbody><tr><td>Number of promoters</td><td>34,245</td><td>1,440</td><td>1,943</td><td>1,528</td><td>39,156</td></tr><tr><td>CGI</td><td>27,026 (78.92) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>253 (17.57) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>363 (18.68) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>9 (0.59) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>27,651 (70.62) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td></tr><tr><td>No CGI</td><td>7,219 (21.08) &lsqb;2.74 &times; 10<sup>&minus;41</sup>&rsqb;</td><td>1,187 (82.43) &lsqb;4.87 &times; 10<sup>&minus;5</sup>&rsqb;</td><td>1,580 (81.32) &lsqb;9.58 &times; 10<sup>&minus;2</sup>&rsqb;</td><td>1,519 (99.41) &lsqb;8.82 &times; 10<sup>&minus;2</sup>&rsqb;</td><td>11,505 (29.38) &lsqb;6.26 &times; 10<sup>&minus;59</sup>&rsqb;</td></tr><tr><td>TATA</td><td>2,539 (7.41) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>188 (13.06) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>567 (29.18) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>434 (28.40) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>3,728 (9.52) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td></tr><tr><td>TATA-less</td><td>31,706 (92.59) &lsqb;1.63 &times; 10<sup>&minus;3</sup>&rsqb;</td><td>1,252 (86.94) &lsqb;1.43 &times; 10<sup>&minus;1</sup>&rsqb;</td><td>1,376 (70.82) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>1,094 (71.60) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>35,428 (90.48) &lsqb;2.02 &times; 10<sup>&minus;1</sup>&rsqb;</td></tr><tr><td>CGI &plus; TATA</td><td>1,613 (4.71) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>33 (2.29) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>58 (2.99) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>1 (0.07) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>1,705 (4.35) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td></tr><tr><td>CGI &plus; TATA-less</td><td>25,413 (74.21) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>220 (15.28) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>305 (15.70) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>8 (0.52) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>25,946 (66.26) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td></tr><tr><td>No CGI &plus; TATA</td><td>926 (2.70) &lsqb;2.19 &times; 10<sup>&minus;1</sup>&rsqb;</td><td>155 (10.76) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>509 (26.20) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>433 (28.34) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>2,023 (5.17) &lsqb;2.09 &times; 10<sup>&minus;4</sup>&rsqb;</td></tr><tr><td>No CGI &plus; TATA-less</td><td>6,293 (18.38) &lsqb;3.72 &times; 10<sup>&minus;41</sup>&rsqb;</td><td>1,032 (71.67) &lsqb;1.12 &times; 10<sup>&minus;4</sup>&rsqb;</td><td>1,071 (55.12) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>1,086 (71.07) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td>9,482 (24.22) &lsqb;2.11 &times; 10<sup>&minus;52</sup>&rsqb;</td></tr></tbody></table> --><!-- <table-wrap-foot><fn id="nt301"><p>We present for each category (CGI, no CGI, etc.) the number of cases for each TSS type, the percent (in parentheses) of the total population in that TSS type, and the Bonferroni corrected <italic>p</italic>-value (in brackets) calculated from a right-sided Fisher's exact test based on the hypergeometric distribution.</p></fn></table-wrap-foot> --></table-wrap>
				<table-wrap content-type="1col" id="pgen-0020054-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.0020054.t004</object-id><label>Table 4</label><caption>
						<p>Basic Statistics on Relation of TATA Box Motifs, CGIs, and Four TSS Types
							for HS17 Transcripts</p>
					</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.t004" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb4col1" align="left" charoff="0" char=""/><col id="tb4col2" align="left" charoff="0" char=""/><col id="tb4col3" align="left" charoff="0" char=""/><col id="tb4col4" align="left" charoff="0" char=""/><col id="tb4col5" align="left" charoff="0" char=""/><col id="tb4col6" align="left" charoff="0" char=""/></colgroup><thead><tr><td align="left" rowspan="2" valign="top"><hr/>Category</td><td colspan="5" valign="middle"><hr/>TSS Type</td></tr><tr><td valign="middle"><hr/>Type A</td><td valign="middle"><hr/>Type B</td><td valign="middle"><hr/>Type C</td><td valign="middle"><hr/>Type D</td><td valign="middle"><hr/>Overall</td></tr></thead><tbody><tr><td valign="middle">Number of promoters</td><td valign="middle">9,269</td><td valign="middle">244</td><td valign="middle">357</td><td valign="middle">385</td><td valign="middle">10,255</td></tr><tr><td valign="middle">CGI</td><td valign="bottom">7,887 (85.09) &lsqb;2.74 &times; 10<sup>&minus;41</sup>&rsqb;</td><td valign="bottom"> 74 (30.33) &lsqb;4.87 &times; 10<sup>&minus;5</sup>&rsqb;</td><td valign="bottom"> 86 (24.09) &lsqb;9.58 &times; 10<sup>&minus;2</sup>&rsqb;</td><td valign="bottom">8 ( 2.08) &lsqb;8.82 &times; 10<sup>&minus;2</sup>&rsqb;</td><td valign="bottom">8,055 (78.55) &lsqb;6.26 &times; 10<sup>&minus;59</sup>&rsqb;</td></tr><tr><td valign="middle">No CGI</td><td valign="bottom">1,382 (14.91) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">170 (69.67) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">271 (75.91) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">377 (97.92) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">2,200 (21.45) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td></tr><tr><td valign="middle">TATA</td><td valign="bottom">791 ( 8.53) &lsqb;1.63 &times; 10<sup>&minus;3</sup>&rsqb;</td><td valign="bottom"> 45 (18.44) &lsqb;1.43 &times; 10<sup>&minus;1</sup>&rsqb;</td><td valign="bottom">106 (29.69) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">101 (26.23) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">1,043 (10.17) &lsqb;2.02 &times; 10<sup>&minus;1</sup>&rsqb;</td></tr><tr><td valign="middle">TATA-less</td><td valign="bottom">8,478 (91.47) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">199 (81.56) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">251 (70.31) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">284 (73.77) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">9,212 (89.83) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td></tr><tr><td valign="middle">CGI &plus; TATA</td><td valign="bottom">574 ( 6.19) &lsqb;7.00 &times; 10<sup>&minus;8</sup>&rsqb;</td><td valign="bottom"> 16 ( 6.56) &lsqb;7.01 &times; 10<sup>&minus;3</sup>&rsqb;</td><td valign="bottom"> 22 ( 6.16) &lsqb;2.99 &times; 10<sup>&minus;2</sup>&rsqb;</td><td valign="bottom">0 ( 0.00) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">612 ( 5.97) &lsqb;1.05 &times; 10<sup>&minus;10</sup>&rsqb;</td></tr><tr><td valign="middle">CGI &plus; TATA-less</td><td valign="bottom">7,313 (78.90) &lsqb;2.62 &times; 10<sup>&minus;20</sup>&rsqb;</td><td valign="bottom"> 58 (23.77) &lsqb;7.80 &times; 10<sup>&minus;3</sup>&rsqb;</td><td valign="bottom"> 64 (17.93) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">8 ( 2.08) &lsqb;5.64 &times; 10<sup>&minus;2</sup>&rsqb;</td><td valign="bottom">7,443 (72.58) &lsqb;4.31 &times; 10<sup>&minus;34</sup>&rsqb;</td></tr><tr><td valign="middle">No CGI &plus; TATA</td><td valign="bottom">217 ( 2.34) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom"> 29 (11.89) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom"> 84 (23.53) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">101 (26.23) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">431 ( 4.20) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td></tr><tr><td valign="middle">No CGI &plus; TATA-less</td><td valign="bottom">1,165 (12.57) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">141 (57.79) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">187 (52.38) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">276 (71.69) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td><td valign="bottom">1,769 (17.25) &lsqb;<xref ref-type="bibr" rid="pgen-0020054-b001">1</xref>&rsqb;</td></tr></tbody></table> --><!-- <table-wrap-foot><fn id="nt401"><p>We present for each category (CGI, no CGI, etc.) the number of cases for each TSS type, the percent (in parentheses) of the total population in that TSS type, and the Bonferroni corrected <italic>p</italic>-value (in brackets) calculated from a right-sided Fisher's exact test based on the hypergeometric distribution.</p></fn></table-wrap-foot> --></table-wrap>
				<p>Based on Bonferroni corrected <italic>p</italic>-values we find that the mouse
					and human datasets differ significantly in a number of promoter features (<xref ref-type="table" rid="pgen-0020054-t003">Tables 3</xref> and <xref ref-type="table" rid="pgen-0020054-t004">4</xref>). Mouse promoters are
					significantly enriched in (a) the number of promoters not associated with CGIs
					in TSS types A and B, and overall; (b) the number of TATA-less promoters in
					group A; (c) the overall number of promoters that have TATA boxes but are not
					associated with CGIs; and (d) the number of TATA-less promoters not associated
					with CGIs in TSS groups A and B, and overall. Conversely, human promoters are
					significantly enriched in (a) the number of promoters associated with CGIs in
					TSS types A and B, and overall; (b) the number of TATA-box-containing promoters
					in TSS type A; (c) the number of TATA-box-containing promoters associated with
					CGIs in TSS types A, B, and C, and overall; and (d) the number of TATA-less
					promoters associated with CGIs in TSS types A and B, and overall. These data
					suggest that there are species-specific solutions for transcriptional initiation
					in mouse and human for the analyzed TSS types.</p>
				<p>There are a number of core PEs other than TATA boxes and Inr elements, such as
					the downstream promoter element (DPE) [<xref ref-type="bibr" rid="pgen-0020054-b023">23</xref>–<xref ref-type="bibr" rid="pgen-0020054-b026">26</xref>], the TFIIB response element (BRE) [<xref ref-type="bibr" rid="pgen-0020054-b027">27</xref>], the motif ten element
					(MTE) [<xref ref-type="bibr" rid="pgen-0020054-b028">28</xref>], and the
					downstream core element (DCE) [<xref ref-type="bibr" rid="pgen-0020054-b029">29</xref>,<xref ref-type="bibr" rid="pgen-0020054-b030">30</xref>]. It
					would be of interest to investigate their presence around mammalian TSSs.
					Unfortunately, such an analysis represents a study on its own and requires
					reliable matrix models of these elements in mammals that are not yet
					available.</p>
			</sec>
			<sec id="s2h">
				<title>Linking TSS Properties and Gene Expression</title>
				<p>We were interested to find out if the TSS types show any correlation with broad
					expression categories. We used association of transcripts with different GO
						[<xref ref-type="bibr" rid="pgen-0020054-b012">12</xref>] and eVOC [<xref ref-type="bibr" rid="pgen-0020054-b013">13</xref>] categories, as well as
					FANTOM3 tissue expression libraries, and analyzed their TSS distribution across
					the four types in mouse. While it is not possible to make definite conclusions
					because of incomplete GO, eVOC, tissue library, and transcript data, we were
					able to find a number of classes that associate with specific TSS types in a
					statistically significant manner (<xref ref-type="table" rid="pgen-0020054-t005">Tables 5</xref>, <xref ref-type="table" rid="pgen-0020054-t006">6</xref>,
					S4, and S5). Moreover, we searched for ortholog transcript groups in mouse and
					human whose promoters preserve enrichment in specific TSS types in both species
						(<xref ref-type="supplementary-material" rid="pgen-0020054-st004">Table
						S4</xref>). Under the conditions of our study we found that 100% of GO
					categories whose mapped transcripts emanate from type B TSSs preserve their
					enrichment; this is true for 64% of GO categories associated with type C TSSs
					and for 80% of GO categories associated with type D TSSs. These results suggest
					that between mouse and human the TSS character within the GO categories is
					largely conserved. Distributions of all mouse TSSs across the four TSS types for
					GO categories and FANTOM3 tissue libraries are provided in <xref ref-type="supplementary-material" rid="pgen-0020054-st005">Table
					S5</xref>.</p>
				<table-wrap content-type="1col" id="pgen-0020054-t005" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.0020054.t005</object-id><label>Table 5</label><caption>
						<p>Enrichment of TSS Types in Selected GO Categories in Mouse</p>
					</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.t005" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb5col1" align="left" charoff="0" char=""/><col id="tb5col2" align="left" charoff="0" char=""/><col id="tb5col3" align="left" charoff="0" char=""/><col id="tb5col4" align="left" charoff="0" char=""/><col id="tb5col5" align="left" charoff="0" char=""/><col id="tb5col6" align="left" charoff="0" char=""/><col id="tb5col7" align="left" charoff="0" char=""/></colgroup><thead><tr><td align="left" rowspan="2"><hr/>GO Category</td><td rowspan="2"><hr/>GO ID</td><td rowspan="2"><hr/>Term</td><td colspan="4"><hr/>Bonferroni Corrected <italic>p</italic>-Values for the TSS Types</td></tr><tr><td><hr/>A</td><td><hr/>B</td><td><hr/>C</td><td><hr/>D</td></tr></thead><tbody><tr><td valign="top">Cellular component</td><td valign="top">GO:0005833</td><td valign="top">Hemoglobin complex</td><td valign="top">1</td><td valign="top">1.74 &times; 10<sup>&minus;6</sup></td><td valign="top">1</td><td valign="top">1</td></tr><tr><td></td><td valign="top">GO:0005579</td><td valign="top">Membrane attack complex</td><td valign="top">1</td><td valign="top">1</td><td valign="top">1</td><td valign="top">1.24 &times; 10<sup>&minus;5</sup></td></tr><tr><td></td><td valign="top">GO:0005576</td><td valign="top">Extracellular region</td><td valign="top">1</td><td valign="top">1</td><td valign="top">4.79 &times; 10<sup>&minus;2</sup></td><td valign="top">2.09 &times; 10<sup>&minus;6</sup></td></tr><tr><td></td><td valign="top">GO:0005794</td><td valign="top">Golgi apparatus</td><td valign="top">2.84 &times; 10<sup>&minus;12</sup></td><td valign="top">1</td><td valign="top">1</td><td valign="top">1</td></tr><tr><td></td><td valign="top">GO:0005634</td><td valign="top">Nucleus</td><td valign="top">6.15 &times; 10<sup>&minus;12</sup></td><td valign="top">1</td><td valign="top">1</td><td valign="top">1</td></tr><tr><td></td><td valign="top">GO:0005737</td><td valign="top">Cytoplasm</td><td valign="top">3.25 &times; 10<sup>&minus;4</sup></td><td valign="top">1</td><td valign="top">1</td><td valign="top">1</td></tr><tr><td></td><td valign="top">GO:0005739</td><td valign="top">Mitochondrion</td><td valign="top">1.23 &times; 10<sup>&minus;9</sup></td><td valign="top">1</td><td valign="top">1</td><td valign="top">1</td></tr><tr><td></td><td valign="top">GO:0005829</td><td valign="top">Cytosol</td><td valign="top">2.28 &times; 10<sup>&minus;2</sup></td><td valign="top">1</td><td valign="top">1</td><td valign="top">1</td></tr><tr><td valign="top">Molecular function</td><td valign="top">GO:0001524</td><td valign="top">Globin</td><td valign="top">1</td><td valign="top">1.74 &times; 10<sup>&minus;6</sup></td><td valign="top">1</td><td valign="top">1</td></tr><tr><td></td><td valign="top">GO:0005125</td><td valign="top">Cytokine activity</td><td valign="top">1</td><td valign="top">1</td><td valign="top">1.98 &times; 10<sup>&minus;7</sup></td><td valign="top">1</td></tr><tr><td></td><td valign="top">GO:0003677</td><td valign="top">DNA binding</td><td valign="top">1.63 &times; 10<sup>&minus;2</sup></td><td valign="top">1</td><td valign="top">1</td><td valign="top">1</td></tr><tr><td></td><td valign="top">GO:0003723</td><td valign="top">RNA binding</td><td valign="top">3.38 &times; 10<sup>&minus;2</sup></td><td valign="top">1</td><td valign="top">1</td><td valign="top">1</td></tr><tr><td></td><td valign="top">GO:0003925</td><td valign="top">Small monomeric GTPase activity</td><td valign="top">1.39 &times; 10<sup>&minus;4</sup></td><td valign="top">1</td><td valign="top">1</td><td valign="top">1</td></tr><tr><td></td><td valign="top">GO:0005524</td><td valign="top">ATP binding</td><td valign="top">4.48 &times; 10<sup>&minus;7</sup></td><td valign="top">1</td><td valign="top">1</td><td valign="top">1</td></tr><tr><td></td><td valign="top">GO:0005525</td><td valign="top">GTP binding</td><td valign="top">1.62 &times; 10<sup>&minus;4</sup></td><td valign="top">1</td><td valign="top">1</td><td valign="top">1</td></tr><tr><td></td><td valign="bottom">GO:0008565</td><td valign="bottom">Protein transporter activity</td><td valign="bottom">2.11 &times; 10<sup>&minus;7</sup></td><td valign="bottom">1</td><td valign="bottom">1</td><td valign="bottom">1</td></tr><tr><td></td><td valign="bottom">GO:0016301</td><td valign="bottom">Kinase activity</td><td valign="bottom">6.82 &times; 10<sup>&minus;5</sup></td><td valign="bottom">1</td><td valign="bottom">1</td><td valign="bottom">1</td></tr><tr><td></td><td valign="bottom">GO:0016740</td><td valign="bottom">Transferase activity</td><td valign="bottom">3.19 &times; 10<sup>&minus;4</sup></td><td valign="bottom">1</td><td valign="bottom">1</td><td valign="bottom">1</td></tr><tr><td valign="top">Biological process</td><td valign="top">GO:0006935</td><td valign="top">Chemotaxis</td><td valign="top">1</td><td valign="top">1</td><td valign="top">1.32 &times; 10<sup>&minus;3</sup></td><td valign="top">1.36 &times; 10<sup>&minus;2</sup></td></tr><tr><td></td><td valign="bottom">GO:0006952</td><td valign="top">Defense response</td><td valign="bottom">1</td><td valign="bottom">1</td><td valign="bottom">3.12 &times; 10<sup>&minus;8</sup></td><td valign="bottom">5.11 &times; 10<sup>&minus;2</sup></td></tr><tr><td></td><td valign="bottom">GO:0006955</td><td valign="top">Immune response</td><td valign="bottom">1</td><td valign="bottom">1</td><td valign="bottom">1.33 &times; 10<sup>&minus;18</sup></td><td valign="bottom">2.60 &times; 10<sup>&minus;4</sup></td></tr><tr><td></td><td valign="top">GO:0006886</td><td valign="top">Intracellular protein transport</td><td valign="bottom">1.77 &times; 10<sup>&minus;12</sup></td><td valign="bottom">1</td><td valign="bottom">1</td><td valign="bottom">1</td></tr><tr><td></td><td valign="bottom">GO:0007049</td><td valign="top">Cell cycle</td><td valign="bottom">3.66 &times; 10<sup>&minus;3</sup></td><td valign="bottom">1</td><td valign="bottom">1</td><td valign="bottom">1</td></tr><tr><td></td><td valign="bottom">GO:0007264</td><td valign="top">Small GTPase-mediated signal transduction</td><td valign="bottom">2.76 &times; 10<sup>&minus;4</sup></td><td valign="bottom">1</td><td valign="bottom">1</td><td valign="bottom">1</td></tr><tr><td></td><td valign="bottom">GO:0015031</td><td valign="bottom">Protein transport</td><td valign="bottom">3.36 &times; 10<sup>&minus;8</sup></td><td valign="bottom">1</td><td valign="bottom">1</td><td valign="bottom">1</td></tr></tbody></table> --><!-- <table-wrap-foot><fn id="nt501"><p>The table shows some statistically significant examples of biased distribution of transcripts from different GO categories in specific TSS groups from all mouse data.</p></fn></table-wrap-foot> --></table-wrap>
				<table-wrap content-type="1col" id="pgen-0020054-t006" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.0020054.t006</object-id><label>Table 6</label><caption>
						<p>Enrichment of TSS Types in Selected eVOC Categories and Tissue Libraries
							in Mouse</p>
					</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.t006" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb6col1" align="left" charoff="0" char=""/><col id="tb6col2" align="left" charoff="0" char=""/><col id="tb6col3" align="left" charoff="0" char=""/><col id="tb6col4" align="left" charoff="0" char=""/><col id="tb6col5" align="left" charoff="0" char=""/><col id="tb6col6" align="left" charoff="0" char=""/></colgroup><thead><tr><td align="left" valign="top">EVOC ID or Tissue Library</td><td valign="top">Terms</td><td colspan="4" valign="top><hr/>Bonferroni Corrected <italic>p</italic>-Value for the TSS Types</td></tr><tr><td><hr/></td><td><hr/></td><td valign="middle"><hr/>A</td><td valign="middle"><hr/>B</td><td valign="middle"><hr/>C</td><td valign="middle"><hr/>D</td></tr></thead><tbody><tr><td valign="middle">EVM:2280168</td><td valign="middle">Lung, male, adult</td><td valign="middle">2.22 &times; 10<sup>&minus;2</sup></td><td valign="middle">1</td><td valign="middle">1</td><td valign="middle">1</td></tr><tr><td valign="middle">EVM:2120010</td><td valign="middle">Whole body, mixture, embryo</td><td valign="middle">3.05 &times; 10<sup>&minus;2</sup></td><td valign="middle">1</td><td valign="middle">1</td><td valign="middle">1</td></tr><tr><td valign="middle">EVM:2270063</td><td valign="middle">Thymus, mixture, embryo</td><td valign="middle">1</td><td valign="middle">1</td><td valign="middle">1</td><td valign="middle">7.51 &times; 10<sup>&minus;3</sup></td></tr><tr><td valign="middle">EVM:2280037</td><td valign="middle">Aorta and vein, male, adult</td><td valign="middle">1</td><td valign="middle">1</td><td valign="middle">1</td><td valign="middle">4.98 &times; 10<sup>&minus;11</sup></td></tr><tr><td valign="middle">EVM:2280087</td><td valign="middle">Cortex, mixture, embryo</td><td valign="middle">1</td><td valign="middle">4.56 &times; 10<sup>&minus;2</sup></td><td valign="middle">1</td><td valign="middle">1</td></tr><tr><td valign="middle">EVM:2280063</td><td valign="middle">Thymus, mixture</td><td valign="middle">9.28 &times; 10<sup>&minus;4</sup></td><td valign="middle">1</td><td valign="middle">1</td><td valign="middle">1</td></tr><tr><td valign="middle">EVM:2250045</td><td valign="middle">Heart, mixture, embryo</td><td valign="middle">3.43 &times; 10<sup>&minus;3</sup></td><td valign="middle">1</td><td valign="middle">1</td><td valign="middle">1</td></tr><tr><td valign="middle">I1</td><td valign="middle">Blastocyst</td><td valign="middle">1.50 &times; 10<sup>&minus;4</sup></td><td valign="middle">1</td><td valign="middle">1</td><td valign="middle">1</td></tr><tr><td valign="middle">I4</td><td valign="middle">Osteoclast-like cell</td><td valign="middle">4.99 &times; 10<sup>&minus;2</sup></td><td valign="middle">1</td><td valign="middle">1</td><td valign="middle">1</td></tr><tr><td valign="middle">I8</td><td valign="middle">LPS-treated bone marrow, macrophage</td><td valign="bottom">4.85 &times; 10<sup>&minus;3</sup></td><td valign="bottom">1</td><td valign="bottom">1</td><td valign="bottom">1</td></tr><tr><td valign="middle">24</td><td valign="middle">ES cell</td><td valign="bottom">8.20 &times; 10<sup>&minus;4</sup></td><td valign="bottom">1</td><td valign="bottom">1</td><td valign="bottom">1</td></tr><tr><td valign="middle">C7</td><td valign="middle">Liver, tumor, adult</td><td valign="bottom">1</td><td valign="bottom">1</td><td valign="bottom">3.13 &times; 10<sup>&minus;2</sup></td><td valign="bottom">2.51 &times; 10<sup>&minus;16</sup></td></tr></tbody></table> --><!-- <table-wrap-foot><fn id="nt601"><p>Some examples of statistically significant enrichment of different TSSs types in eVOC categories and tissue libraries from all mouse data.</p></fn></table-wrap-foot> --></table-wrap>
				<p>We further analyzed several specific cases. For many GO categories we found that
					transcripts associated with them prefer specific GC-rich/GC-poor transcription
					initiation frameworks (<xref ref-type="table" rid="pgen-0020054-t005">Table
						5</xref>). For example, the immune response group (GO:0006955) (<xref ref-type="fig" rid="pgen-0020054-g006">Figure 6</xref>) appears with 1.58-,
					4.85-, and 3.35-fold more transcripts having TSSs of type B, C, and D,
					respectively, than one would expect based on the proportion of transcripts in
					these groups in our reference mouse data. The enrichment in type C and D TSSs is
					statistically significant (Bonferroni-corrected right-sided Fisher's exact test,
						<italic>p</italic> = 1.33 × 10<sup>−18</sup> and <italic>p =</italic> 2.60 ×
						10<sup>−4</sup>, respectively). Based on this, we conclude that the
					transcript group GO:0006955 is characterized by increased participation of
					transcripts from TSS types that are AT-rich upstream or downstream. We analyzed
					in more detail the genomic organization of loci corresponding to genes from the
					most overrepresented TSS type (type C) for this GO. We found that TSSs of type C
					map to 36 nonredundant genes, of which two are in bidirectional promoters
					(2/36), which means these are underrepresented for type C TSSs relative to the
					genome average. There are 23 genes (64%) that are appearing in gene family
					clusters, that is, these genes are highly overrepresented for type C TSSs
					relative to the genome average. Finally, genes with type C TSSs have small
					genomic span: 34 out of 36 are less than 25 kb long, which is again more than
					one would expect based on the genome average. Most genes in the category
					GO:0006955 are short (the majority are actually less than 10 kb), are clustered
					with other members of the same families, and are not bidirectionally
					transcribed. This analysis illustrates a specific genomic organization of genes
					with TSSs of type C in this GO group. Thus, TSS properties may be associated
					with genomic organization.</p>
				<fig id="pgen-0020054-g006" position="float">
					<object-id pub-id-type="doi">10.1371/journal.pgen.0020054.g006</object-id>
					<label>Figure 6</label>
					<caption>
						<title>Distribution of TSSs for Transcripts Related to Immune Response
							through GO:0006955</title>
						<p>There are 1.58-, 4.85-, and 3.35-fold more transcripts having TSS types
							B, C, and D than one would expect based on the proportion of transcripts
							in these groups in our reference mouse data. Enrichment is statistically
							significant for types C and D based on Bonferroni corrected
								<italic>p</italic>-values obtained by the right-sided Fisher's exact
							test (<xref ref-type="table" rid="pgen-0020054-t005">Table
							5</xref>).</p>
					</caption>
					<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.g006" xlink:type="simple"/>
				</fig>
				<p>In <xref ref-type="table" rid="pgen-0020054-t005">Table 5</xref>, one can see
					that GC-rich TSSs relate to genes responsible for various binding and protein
					transport activities. These functions usually occur in different regions of the
					cell and are reflected in the diverse compartments that are enriched for type A
					TSSs. AT-rich TSSs (types C and D), on the other hand, are enriched in processes
					relating to defense responses to the environment. TSSs of the membrane attack
					complex (GO:0005579), defense response (GO:0006952), and immune response
					(GO:0006955) are enriched in type D TSSs, while the last two of these (defense
					and immune response) and cytocine activity (GO:0005125) are enriched in type C
					TSSs. Globin group (GO:0001524) and hemoglobin complex (GO:0005833) are enriched
					in type B TSSs. These findings suggest a preference of different functional
					transcript groups for specific TSS types.</p>
				<p>Similarly, for transcript groups based on eVOC terms, we find that they prefer
					GC-rich or GC-poor transcription initiation frameworks, depending on the eVOC
					category. For example, thymus-expressed transcripts (EVM:2270063 and
					EVM:2280063) (<xref ref-type="table" rid="pgen-0020054-t006">Table 6</xref>)
					seem to prefer either type A or D TSSs. The same is the case for transcripts
					classified according to cardiovascular function (EVM:2280037 and EVM:2250045)
						(<xref ref-type="table" rid="pgen-0020054-t006">Table 6</xref>).</p>
			</sec>
			<sec id="s2i">
				<title>Conclusions</title>
				<p>We have introduced a different way to characterize TSSs, which connects TSS
					properties to the GC content of the immediately upstream and downstream regions.
					This implicitly links the TSS type with PEs that are residing in the TSS
					neighborhood. We were able to delineate transcription initiation active domains
					in the mouse and human genomes and observed fundamental similarities in the
					transcription initiation active domains in the two species. Looking separately
					at the GC content upstream and downstream of TSSs provides a useful paradigm to
					view certain phenomena in a clearer and more meaningful manner. We found that
					two of the TSS types, types C and D, possess positionally very well defined
					AT-rich regions [−35, −20] relative to the TSS, suggesting the significant role
					of AT-rich sequences such as TATA boxes in the control of TSSs of these types.
					Our analysis documents that various initiating dinucleotides show very specific
					preferences for the TSS types we considered, are present in statistically
					significant proportions of the TSSs in our datasets, and are almost all
					different from the consensus dinucleotide. Very specific sets of initiating
					dinucleotides are associated with different TSS types, and surrounding GC
					content is well correlated with the types of these dinucleotides. This suggests
					the potential presence of different Inr elements that may be characteristic for
					each of the TSS types and associated with different nucleotide characteristics
					of the surrounding domain.</p>
				<p>We have shown that different TSS types associate with different PEs, that regions
					upstream and downstream of different TSS types are characterized by different
					collections of PEs, and that the putative PE content (for the top 10% of PEs) of
					the TSS surroundings generally differs for the TSS types. All these findings
					suggest likely control of the respective transcripts by different collections of
					significant PEs residing upstream or downstream of the TSS. Our results on TSS
					properties relative to CGIs, TATA boxes, and Inr elements in mouse and human
					suggest species-specific adaptation. Finally, we have shown a number of examples
					of transcript groups obtained on the basis of different ontologies or tissue
					libraries that have statistically significant enrichment in at least one of the
					TSS types. This has provided a link between TSS characteristics and expression
					data.</p>
				<p>We believe that the results of this analysis will help in better understanding
					the general transcription regulation properties of mammalian promoters, and
					prove useful for further development and enhancement of promoter and gene
					prediction tools.</p>
			</sec>
		</sec>
		<sec id="s3">
			<title>Materials and Methods</title>
			<sec id="s3a">
				<title>TSSs.</title>
				<p>We constructed two highly accurate sets (one for mouse and one for human) of TSSs
					and of the promoter sequences covering the span [−100, +100] relative to these
					TSSs. These datasets are available at <ext-link ext-link-type="uri" xlink:href="http://www.sanbi.ac.za" xlink:type="simple">http://www.sanbi.ac.za</ext-link> and were obtained as follows. If the
					first 5′ nucleotide of the CAGE tag or 5′ ditag (<ext-link ext-link-type="uri" xlink:href="http://fantom31p.gsc.riken.jp/cage_analysis/export" xlink:type="simple">http://fantom31p.gsc.riken.jp/cage_analysis/export</ext-link>) coincided
					with the first 5′ nucleotide of the full-length cDNA
					(http://fantom.gsc.riken.go.jp/download.html), the TSS determined by this tag
					was selected. Also, in cases when this condition did not hold, we selected TSSs
					based on the following requirements: the TSS is a representative TSS location
					from a tag cluster that has at least ten tags, the representative TSS is
					supported by at least six tags, and there is at least one other piece of
					transcriptional evidence associated with this tag cluster (expressed sequence
					tag, full-length cDNA, or long SAGE; <ext-link ext-link-type="uri" xlink:href="http://fantom.gsc.riken.go.jp/download.html" xlink:type="simple">http://fantom.gsc.riken.go.jp/download.html</ext-link>). In this way, we
					compiled a mouse reference promoter set of 39,156 promoters and a human
					reference promoter set of 10,255 promoters. These two sets are used for all our
					analyses.</p>
				<p>Randomly selected DNA sequences from mouse were used as the background set for
					analysis of TF binding sites in mouse promoters. These DNA sequences were 200 bp
					long and selected randomly from all mouse chromosomes, with the number of
					sequences from each chromosome proportional to the length of the chromosome. In
					total we selected 41,000 such random DNA sequences (<xref ref-type="supplementary-material" rid="pgen-0020054-sd001">Dataset
					S1</xref>).</p>
			</sec>
			<sec id="s3b">
				<title>TSS types.</title>
				<p>We determined the GC content of the [−100, −1] region and the [+1, +100] region
					relative to TSS location for each individual TSS. The TSS is considered to be
					between positions −1 and +1. The upstream or downstream segment was defined as
					GC-rich if G + C &gt; 50% in the region. Otherwise, the region was defined
					as AT-rich. Four types of TSSs were defined based on the GC richness in the
					upstream and downstream segments as follows (<xref ref-type="table" rid="pgen-0020054-t001">Table 1</xref>): type A, GC-rich upstream and
					downstream (GC-GC); type B, GC-rich upstream and AT-rich downstream (GC-AT);
					type C, AT-rich upstream and GC-rich downstream (AT-GC); and type D, AT-rich
					upstream and downstream (AT-AT). Each TSS can be represented as a point in the
						<italic>x–y</italic> plane, where <italic>x</italic> corresponds to the GC
					content upstream and <italic>y</italic> corresponds to the GC content downstream
					of the considered TSS. For mouse and human these distributions are depicted in
						<xref ref-type="fig" rid="pgen-0020054-g001">Figure 1</xref>A.</p>
			</sec>
			<sec id="s3c">
				<title>TF binding sites in promoters.</title>
				<p>We used all available matrix models of TFBSs contained in the TRANSFAC
					Professional (version 8.4) database [<xref ref-type="bibr" rid="pgen-0020054-b031">31</xref>] and mapped them to the extracted
					sequences. We used minSUM profiles for the threshold of the matrix models since
					these contain the optimized threshold values for the core and matrix scores
						[<xref ref-type="bibr" rid="pgen-0020054-b032">32</xref>]. The thresholds in
					minSUM are based on optimization that provides the minimum sum of false positive
					and false negative TFBS predictions. To determine the overrepresentation of
					TFBSs found in the target set, we used the method of Bajic et al. [<xref ref-type="bibr" rid="pgen-0020054-b015">15</xref>]. All TFBSs mapped to
					target promoters were ranked based on their ORI as defined by Bajic et al.
						[<xref ref-type="bibr" rid="pgen-0020054-b015">15</xref>]. For ORI = 1 or
					close to this value, there is no overrepresentation of the motif in the target
					promoter group. We also estimated the likelihood of observing these TFBSs in the
					target set using the background random promoter set as a reference. The null
					hypothesis was that the proportion of sequences in the target set in which a
					particular PE was found was the same as that in the background set. The
						<italic>p</italic>-values were calculated using right-sided Fisher's exact
					tests based on hypergeometric distribution. The original
					<italic>p</italic>-values were subjected to Bonferroni correction for
					multiplicity testing. If the corrected <italic>p</italic>-value of the pattern
					was not greater than 0.05, we placed a plus sign after the ORI value in the
					provided tabular reports.</p>
			</sec>
			<sec id="s3d">
				<title>Most significant PEs.</title>
				<p>For each of the TSS types in mouse, we analyzed the 150 top-ranked PEs (based on
					the values of ORI). This represents about 10% of all (1,428) PEs analyzed. We
					also required that the PEs have an ORI of at least 1.5 and that the PE be found
					in at least 10% of the target sequences. Details are explained in <xref ref-type="supplementary-material" rid="pgen-0020054-st001">Tables
						S1</xref>–<xref ref-type="supplementary-material" rid="pgen-0020054-st003">S3</xref>.</p>
			</sec>
			<sec id="s3e">
				<title>TATA boxes.</title>
				<p>The TATA box model used was based on that of Bucher [<xref ref-type="bibr" rid="pgen-0020054-b022">22</xref>]. The threshold used was 0.75, while score
					was normalized between zero and one (analogous to Bajic et al. [<xref ref-type="bibr" rid="pgen-0020054-b033">33</xref>]). A TATA box was
					considered detected if the maximum value of the score in the [−50, −1] region
					was higher than the threshold. Only one TATA box was assumed in the [−50, −1]
					region.</p>
			</sec>
			<sec id="s3f">
				<title>eVOC, GO, and tissue expression libraries.</title>
				<p>In order to assess the biological significance of our TSS classification system,
					we assigned TSSs according to different GO and eVOC categories, as well as
					tissue libraries in FANTOM3 collection (<ext-link ext-link-type="uri" xlink:href="http://fantom.gsc.riken.go.jp/download.html" xlink:type="simple">http://fantom.gsc.riken.go.jp/download.html</ext-link>). GO–FANTOM mapping
					data was downloaded from the RIKEN Web site (<ext-link ext-link-type="ftp" xlink:href="ftp://fantom.gsc.riken.jp/FANTOM3/annotation/fantomdb-3.0/anndata.txt.gz" xlink:type="simple">ftp://fantom.gsc.riken.jp/FANTOM3/annotation/fantomdb-3.0/anndata.txt.gz</ext-link>).
					The eVOC system consists of a set of orthogonal controlled vocabularies that
					unify gene expression data by mapping between the genome sequence and expression
					phenotype information. The eVOC human anatomy ontology [<xref ref-type="bibr" rid="pgen-0020054-b013">13</xref>] and the newly developed mouse adult and
					developmental ontologies (<ext-link ext-link-type="uri" xlink:href="http://www.evocontology.org" xlink:type="simple">http://www.evocontology.org</ext-link>) have been mapped to the FANTOM3
					library descriptions, providing a hierarchical representation of tissues, cell
					types, and developmental stage information. This allows for a standardized
					analysis of gene expression and promoter profiles independent of the original
					annotation vocabulary used in the original dataset.</p>
				<p>For the generation of the results presented in <xref ref-type="supplementary-material" rid="pgen-0020054-st004">Table S4</xref>,
					we used ortholog gene groups between mouse and human as defined at <ext-link ext-link-type="ftp" xlink:href="ftp://ftp.ncbi.nih.gov/pub/HomoloGene." xlink:type="simple">ftp://ftp.ncbi.nih.gov/pub/HomoloGene</ext-link>. <xref ref-type="supplementary-material" rid="pgen-0020054-st005">Table S5</xref>
					for mouse data contains statistics of all GO and tissue expression libraries
					from FANTOM3, complemented by the Bonferroni corrected <italic>p</italic>-value
					(right-sided Fisher's exact test based on hypergeometric distribution) for the
					null hypothesis that the proportion of TSSs of a specific type in the considered
					GO/tissue library is the same as what one can expect based on the distribution
					of these TSSs in mouse.</p>
			</sec>
		</sec>
		<sec id="s4">
			<title>Supporting Information</title>
			<supplementary-material id="pgen-0020054-sd001" mimetype="application/zip" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.sd001" xlink:type="simple">
				<label>Dataset S1</label>
				<caption>
					<title>Supplementary Nonpromoter Data</title>
					<p>(2.5 MB ZIP)</p>
				</caption>
			</supplementary-material>
			<supplementary-material id="pgen-0020054-sg001" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.sg001" xlink:type="simple">
				<label>Figure S1</label>
				<caption>
					<title>Number of TSSs of the Four Types in Human and Mouse Genomes under the
						Change of Parameters</title>
					<p>Blue, green, red, and light blue correspond to TSSs of type A, B, C, and D,
						respectively. From graphs in the first row we observe that when the length
						of the region considered changes, the numbers of TSSs of the different types
						remain almost unchanged. We changed the length of upstream and downstream
						regions from [−<italic>x</italic>, −1] and [+1, +<italic>x</italic>],
						respectively, with values of <italic>x</italic> from 50 to 150. From graphs
						in the second row we observe that the numbers of TSSs within the four types
						gradually change with the change of threshold for GC content. We changed
						this threshold from 40% to 60%.</p>
					<p>(24 KB PDF)</p>
				</caption>
			</supplementary-material>
			<supplementary-material id="pgen-0020054-sg002" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.sg002" xlink:type="simple">
				<label>Figure S2</label>
				<caption>
					<title>Distributions of TFs Found to Be Common among the Top 150 PEs in
						Comparisons of Different TSS Types</title>
					<p>(A) Comparison of types A and B upstream regions.</p>
					<p>(B) Comparison of types B and D downstream regions.</p>
					<p>(C) Comparison of types A and C downstream regions.</p>
					<p>(D) Comparison of types C and D upstream regions.</p>
					<p>(40 KB PDF)</p>
				</caption>
			</supplementary-material>
			<supplementary-material id="pgen-0020054-st001" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.st001" xlink:type="simple">
				<label>Table S1</label>
				<caption>
					<title>List of Top 150 PEs That Appear with a Frequency of 10% or Greater in
						Upstream and Downstream Regions of Different TSS Categories</title>
					<p>Comparison is carried out against a background of random mouse sequences.
						Ranking is based on ORI value. The higher the ORI, the higher the rank. We
						present results for the four TSS types (A, B, C, and D). For each PE we give
						the strand where it is found (+1 or −1), name of TFBS, ORI value, percentage
						of promoters in the target set that contain the PE, percentage of sequences
						in the background set that contain the PE, probability of finding the PE in
						the target set (given as one prediction per nucleotide), probability of
						finding the PE in the background set (given as one prediction per
						nucleotide), and Bonferroni corrected <italic>p</italic>-value. A plus sign
						added after the ORI value indicates that the PE is enriched in a
						statistically significant manner at the level 0.05. Almost all top-ranked
						elements appear to be statistically significantly enriched in the target
						sets.</p>
					<p>(329 KB PDF)</p>
				</caption>
			</supplementary-material>
			<supplementary-material id="pgen-0020054-st002" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.st002" xlink:type="simple">
				<label>Table S2</label>
				<caption>
					<title>Common and Specific TFBSs in the Four TSS Types</title>
					<p>PEs are compared relative to the same GC richness and same location (upstream
						or downstream) in different TSS types. The signs plus or minus indicate
						whether the PE was found to be significantly enriched in the considered
						region for the considered TSS type. For example, the first column (yellow),
						which shows comparison between the AT-rich downstream domains in TSS types B
						and D, contains a common element denoted as “+ − Ets.” This means that Ets
						was found significantly enriched for the B type, but its enrichment was not
						significant for D type. When an element is unique for one or another group,
						then it is associated only with one plus or minus sign.</p>
					<p>(53 KB PDF)</p>
				</caption>
			</supplementary-material>
			<supplementary-material id="pgen-0020054-st003" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.st003" xlink:type="simple">
				<label>Table S3</label>
				<caption>
					<title>List of Significant PEs Unique and Common for Different TSS Types in the
						Upstream and Downstream Segments</title>
					<p>The yellow highlighted TFs are unique for the considered groups when compared
						with the same upstream or downstream segment of another TSS type with the
						same GC richness.</p>
					<p>(47 KB PDF)</p>
				</caption>
			</supplementary-material>
			<supplementary-material id="pgen-0020054-st004" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.st004" xlink:type="simple">
				<label>Table S4</label>
				<caption>
					<title>GO Categories That Preserve Enrichment in Specific TSS Types between
						Human and Mouse</title>
					<p>We considered only those TSSs whose generated transcripts belong to the same
						homology group as defined on the NCBI Web site (<ext-link ext-link-type="ftp" xlink:href="ftp://ftp.ncbi.nih.gov/pub/HomoloGene" xlink:type="simple">ftp://ftp.ncbi.nih.gov/pub/HomoloGene</ext-link>).
						We only considered GO categories that were supported by at least 60 TSSs and
						where the target TSS type was supported by at least three TSSs.</p>
					<p>(96 KB PDF)</p>
				</caption>
			</supplementary-material>
			<supplementary-material id="pgen-0020054-st005" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pgen.0020054.st005" xlink:type="simple">
				<label>Table S5</label>
				<caption>
					<title>All GO and Tissue-Specific Libraries with Distribution of TSSs across the
						Four TSS Types in Mouse</title>
					<p>The table presents the total number of TSSs associated with the category (GO
						or expression library), the number of TSSs of individual TSS type, the
						percentage of TSSs in that TSS type, enrichment of TSSs in the TSS type
						relative to what can be expected based on the distribution of all TSSs in
						mouse across all four TSS types, and Bonferroni corrected
						<italic>p</italic>-values calculated based on right-sided Fisher's exact
						tests for the null hypothesis that the proportion of TSS type found in the
						target group is the same as that of the general mouse distribution. For
						example, there are 253 transcripts associated with GO:0006955. Of these, 52
						transcripts have a TSS of type C. For the number of transcripts in this GO
						category, one would expect only 11 transcripts with TSSs of type C. Thus, in
						this GO category, we have 4.85-fold enrichment of transcripts of this type
						(compared to what we would expect based on the distribution of all
						transcripts across the four TSS types). If in any of the GO/eVOC categories
						or tissue libraries, at least one of the TSS groups of transcripts has
						enrichment that is 1.5-fold or greater than the expected value, we consider
						such TSS type overrepresented.</p>
					<p>(2.9 MB PDF)</p>
				</caption>
			</supplementary-material>
		</sec>
	</body>
	<back>
		<ack/>
		
		<glossary>
			<title>Abbreviations</title>
			<def-list>
				<def-item>
					<term>CGI</term>
					<def>
						<p>CpG island</p>
					</def>
				</def-item>
				<def-item>
					<term>GO</term>
					<def>
						<p>Gene Ontology</p>
					</def>
				</def-item>
				<def-item>
					<term>Inr</term>
					<def>
						<p>initiator</p>
					</def>
				</def-item>
				<def-item>
					<term>ORI</term>
					<def>
						<p>overrepresentation index</p>
					</def>
				</def-item>
				<def-item>
					<term>PE</term>
					<def>
						<p>promoter element</p>
					</def>
				</def-item>
				<def-item>
					<term>TF</term>
					<def>
						<p>transcription factor</p>
					</def>
				</def-item>
				<def-item>
					<term>TFBS</term>
					<def>
						<p>transcription factor binding site</p>
					</def>
				</def-item>
				<def-item>
					<term>TSS</term>
					<def>
						<p>transcription start site</p>
					</def>
				</def-item>
			</def-list>
		</glossary>
		<ref-list>
			<title>References</title>
			<ref id="pgen-0020054-b001">
				<label>1</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Suzuki</surname>
							<given-names>Y</given-names>
						</name>
						<name name-style="western">
							<surname>Yamashita</surname>
							<given-names>R</given-names>
						</name>
						<name name-style="western">
							<surname>Sugano</surname>
							<given-names>S</given-names>
						</name>
						<name name-style="western">
							<surname>Nakai</surname>
							<given-names>K</given-names>
						</name>
					</person-group>
					<year>2004</year>
					<article-title>DBTSS, Database of transcriptional start sites: Progress report
						2004.</article-title>
					<source>Nucleic Acids Res</source>
					<volume>32</volume>
					<fpage>D78</fpage>
					<lpage>D81</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b002">
				<label>2</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Suzuki</surname>
							<given-names>Y</given-names>
						</name>
						<name name-style="western">
							<surname>Yamashita</surname>
							<given-names>R</given-names>
						</name>
						<name name-style="western">
							<surname>Shirota</surname>
							<given-names>M</given-names>
						</name>
						<name name-style="western">
							<surname>Sakakibara</surname>
							<given-names>Y</given-names>
						</name>
						<name name-style="western">
							<surname>Chiba</surname>
							<given-names>J</given-names>
						</name>
						<etal/>
					</person-group>
					<year>2004</year>
					<article-title>Large-scale collection and characterization of promoters of human
						and mouse genes.</article-title>
					<source>In Silico Biol</source>
					<volume>4</volume>
					<fpage>0036</fpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b003">
				<label>3</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Aerts</surname>
							<given-names>S</given-names>
						</name>
						<name name-style="western">
							<surname>Thijs</surname>
							<given-names>G</given-names>
						</name>
						<name name-style="western">
							<surname>Dabrowski</surname>
							<given-names>M</given-names>
						</name>
						<name name-style="western">
							<surname>Moreau</surname>
							<given-names>Y</given-names>
						</name>
						<name name-style="western">
							<surname>De Moor</surname>
							<given-names>B</given-names>
						</name>
					</person-group>
					<year>2004</year>
					<article-title>Comprehensive analysis of the base composition around the
						transcription start site in metazoan.</article-title>
					<source>BMC Genomics</source>
					<volume>5</volume>
					<fpage>34</fpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b004">
				<label>4</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Imanishi</surname>
							<given-names>T</given-names>
						</name>
						<name name-style="western">
							<surname>Itoh</surname>
							<given-names>T</given-names>
						</name>
						<name name-style="western">
							<surname>Suzuki</surname>
							<given-names>Y</given-names>
						</name>
						<name name-style="western">
							<surname>O'Donovan</surname>
							<given-names>C</given-names>
						</name>
						<name name-style="western">
							<surname>Fukuchi</surname>
							<given-names>S</given-names>
						</name>
						<etal/>
					</person-group>
					<year>2004</year>
					<article-title>Integrative annotation of 21,037 human genes validated by
						full-length cDNA clones.</article-title>
					<source>PLoS Biol</source>
					<volume>2</volume>
					<elocation-id>e162.</elocation-id>
					<comment>DOI: <ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pbio.0020162" xlink:type="simple">10.1371/journal.pbio.0020162</ext-link></comment>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b005">
				<label>5</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Carninci</surname>
							<given-names>P</given-names>
						</name>
						<name name-style="western">
							<surname>Kasukawa</surname>
							<given-names>T</given-names>
						</name>
						<name name-style="western">
							<surname>Katayama</surname>
							<given-names>S</given-names>
						</name>
						<name name-style="western">
							<surname>Gough</surname>
							<given-names>J</given-names>
						</name>
						<name name-style="western">
							<surname>Frith</surname>
							<given-names>MC</given-names>
						</name>
						<etal/>
					</person-group>
					<year>2005</year>
					<article-title>The transcriptional landscape of the mammalian
						genome.</article-title>
					<source>Science</source>
					<volume>309</volume>
					<fpage>1559</fpage>
					<lpage>1563</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b006">
				<label>6</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Vinogradov</surname>
							<given-names>AE</given-names>
						</name>
					</person-group>
					<year>2005</year>
					<article-title>Noncoding DNA, isochores and gene expression: Nucleosome
						formation potential.</article-title>
					<source>Nucleic Acids Res</source>
					<volume>33</volume>
					<fpage>559</fpage>
					<lpage>563</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b007">
				<label>7</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Vinogradov</surname>
							<given-names>AE</given-names>
						</name>
					</person-group>
					<year>2003</year>
					<article-title>Isochores and tissue-specificity.</article-title>
					<source>Nucleic Acids Res</source>
					<volume>31</volume>
					<fpage>5212</fpage>
					<lpage>5220</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b008">
				<label>8</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Vinogradov</surname>
							<given-names>AE</given-names>
						</name>
					</person-group>
					<year>2003</year>
					<article-title>DNA helix: The importance of being GC-rich.</article-title>
					<source>Nucleic Acids Res</source>
					<volume>31</volume>
					<fpage>1838</fpage>
					<lpage>1844</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b009">
				<label>9</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Levitsky</surname>
							<given-names>VG</given-names>
						</name>
						<name name-style="western">
							<surname>Podkolodnaya</surname>
							<given-names>OA</given-names>
						</name>
						<name name-style="western">
							<surname>Kolchanov</surname>
							<given-names>NA</given-names>
						</name>
						<name name-style="western">
							<surname>Podkolodny</surname>
							<given-names>NL</given-names>
						</name>
					</person-group>
					<year>2001</year>
					<article-title>Nucleosome formation potential of eukaryotic DNA: Calculation and
						promoters analysis.</article-title>
					<source>Bioinformatics</source>
					<volume>17</volume>
					<fpage>998</fpage>
					<lpage>1010</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b010">
				<label>10</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Shiraki</surname>
							<given-names>T</given-names>
						</name>
						<name name-style="western">
							<surname>Kondo</surname>
							<given-names>S</given-names>
						</name>
						<name name-style="western">
							<surname>Katayama</surname>
							<given-names>S</given-names>
						</name>
						<name name-style="western">
							<surname>Waki</surname>
							<given-names>K</given-names>
						</name>
						<name name-style="western">
							<surname>Kasukawa</surname>
							<given-names>T</given-names>
						</name>
						<etal/>
					</person-group>
					<year>2003</year>
					<article-title>Cap analysis gene expression for high-throughput analysis of
						transcriptional starting point and identification of promoter
						usage.</article-title>
					<source>Proc Natl Acad Sci U S A</source>
					<volume>100</volume>
					<fpage>15776</fpage>
					<lpage>15781</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b011">
				<label>11</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Ng</surname>
							<given-names>P</given-names>
						</name>
						<name name-style="western">
							<surname>Wei</surname>
							<given-names>CL</given-names>
						</name>
						<name name-style="western">
							<surname>Sung</surname>
							<given-names>WK</given-names>
						</name>
						<name name-style="western">
							<surname>Chiu</surname>
							<given-names>KP</given-names>
						</name>
						<name name-style="western">
							<surname>Lipovich</surname>
							<given-names>L</given-names>
						</name>
						<etal/>
					</person-group>
					<year>2005</year>
					<article-title>Gene identification signature (GIS) analysis for transcriptome
						characterization and genome annotation.</article-title>
					<source>Nat Methods</source>
					<volume>2</volume>
					<fpage>105</fpage>
					<lpage>111</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b012">
				<label>12</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Ashburner</surname>
							<given-names>M</given-names>
						</name>
						<name name-style="western">
							<surname>Ball</surname>
							<given-names>CA</given-names>
						</name>
						<name name-style="western">
							<surname>Blake</surname>
							<given-names>JA</given-names>
						</name>
						<name name-style="western">
							<surname>Botstein</surname>
							<given-names>D</given-names>
						</name>
						<name name-style="western">
							<surname>Butler</surname>
							<given-names>H</given-names>
						</name>
						<etal/>
					</person-group>
					<year>2000</year>
					<article-title>Gene Ontology: Tool for the unification of biology. The Gene
						Ontology Consortium.</article-title>
					<source>Nat Genet</source>
					<volume>25</volume>
					<fpage>25</fpage>
					<lpage>29</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b013">
				<label>13</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Kelso</surname>
							<given-names>J</given-names>
						</name>
						<name name-style="western">
							<surname>Visagie</surname>
							<given-names>J</given-names>
						</name>
						<name name-style="western">
							<surname>Theiler</surname>
							<given-names>G</given-names>
						</name>
						<name name-style="western">
							<surname>Christoffels</surname>
							<given-names>A</given-names>
						</name>
						<name name-style="western">
							<surname>Bardien</surname>
							<given-names>S</given-names>
						</name>
						<etal/>
					</person-group>
					<year>2003</year>
					<article-title>eVOC: A controlled vocabulary for unifying gene expression
						data.</article-title>
					<source>Genome Res</source>
					<volume>13</volume>
					<fpage>1222</fpage>
					<lpage>1230</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b014">
				<label>14</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Kel-Margoulis</surname>
							<given-names>OV</given-names>
						</name>
						<name name-style="western">
							<surname>Tchekmenev</surname>
							<given-names>D</given-names>
						</name>
						<name name-style="western">
							<surname>Kel</surname>
							<given-names>AE</given-names>
						</name>
						<name name-style="western">
							<surname>Goessling</surname>
							<given-names>E</given-names>
						</name>
						<name name-style="western">
							<surname>Hornischer</surname>
							<given-names>K</given-names>
						</name>
						<etal/>
					</person-group>
					<year>2003</year>
					<article-title>Composition-sensitive analysis of the human genome for regulatory
						signals.</article-title>
					<source>In Silico Biol</source>
					<volume>3</volume>
					<fpage>0013</fpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b015">
				<label>15</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Bajic</surname>
							<given-names>VB</given-names>
						</name>
						<name name-style="western">
							<surname>Choudhary</surname>
							<given-names>V</given-names>
						</name>
						<name name-style="western">
							<surname>Hock</surname>
							<given-names>CK</given-names>
						</name>
					</person-group>
					<year>2004</year>
					<article-title>Content analysis of the core promoter region of human
						genes.</article-title>
					<source>In Silico Biol</source>
					<volume>4</volume>
					<fpage>109</fpage>
					<lpage>125</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b016">
				<label>16</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Kadonaga</surname>
							<given-names>JT</given-names>
						</name>
					</person-group>
					<year>2004</year>
					<article-title>Regulation of RNA polymerase II transcription by
						sequence-specific DNA binding factors.</article-title>
					<source>Cell</source>
					<volume>116</volume>
					<fpage>247</fpage>
					<lpage>257</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b017">
				<label>17</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Kim</surname>
							<given-names>TH</given-names>
						</name>
						<name name-style="western">
							<surname>Barrera</surname>
							<given-names>LO</given-names>
						</name>
						<name name-style="western">
							<surname>Zheng</surname>
							<given-names>M</given-names>
						</name>
						<name name-style="western">
							<surname>Qu</surname>
							<given-names>C</given-names>
						</name>
						<name name-style="western">
							<surname>Singer</surname>
							<given-names>MA</given-names>
						</name>
						<etal/>
					</person-group>
					<year>2005</year>
					<article-title>A high-resolution map of active promoters in the human
						genome.</article-title>
					<source>Nature</source>
					<volume>436</volume>
					<fpage>876</fpage>
					<lpage>880</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b018">
				<label>18</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Mueller</surname>
							<given-names>CR</given-names>
						</name>
						<name name-style="western">
							<surname>Maire</surname>
							<given-names>P</given-names>
						</name>
						<name name-style="western">
							<surname>Schibler</surname>
							<given-names>U</given-names>
						</name>
					</person-group>
					<year>1990</year>
					<article-title>DBP, a liver-enriched transcriptional activator, is expressed
						late in ontogeny and its tissue specificity is determined
						posttranscriptionally.</article-title>
					<source>Cell</source>
					<volume>61</volume>
					<fpage>279</fpage>
					<lpage>291</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b019">
				<label>19</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Shimizu</surname>
							<given-names>H</given-names>
						</name>
						<name name-style="western">
							<surname>Kang</surname>
							<given-names>M</given-names>
						</name>
						<name name-style="western">
							<surname>Iitsuka</surname>
							<given-names>Y</given-names>
						</name>
						<name name-style="western">
							<surname>Ichinose</surname>
							<given-names>M</given-names>
						</name>
						<name name-style="western">
							<surname>Tokuhisa</surname>
							<given-names>T</given-names>
						</name>
						<etal/>
					</person-group>
					<year>2000</year>
					<article-title>Identification of an optimal Ncx binding sequence required for
						transcriptional activation.</article-title>
					<source>FEBS Lett</source>
					<volume>475</volume>
					<fpage>170</fpage>
					<lpage>174</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b020">
				<label>20</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Shirasawa</surname>
							<given-names>S</given-names>
						</name>
						<name name-style="western">
							<surname>Yunker</surname>
							<given-names>AM</given-names>
						</name>
						<name name-style="western">
							<surname>Roth</surname>
							<given-names>KA</given-names>
						</name>
						<name name-style="western">
							<surname>Brown</surname>
							<given-names>GA</given-names>
						</name>
						<name name-style="western">
							<surname>Horning</surname>
							<given-names>S</given-names>
						</name>
						<etal/>
					</person-group>
					<year>1997</year>
					<article-title>Enx (Hox11L1)-deficient mice develop myenteric neuronal
						hyperplasia and megacolon.</article-title>
					<source>Nat Med</source>
					<volume>3</volume>
					<fpage>646</fpage>
					<lpage>650</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b021">
				<label>21</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Hatano</surname>
							<given-names>M</given-names>
						</name>
						<name name-style="western">
							<surname>Aoki</surname>
							<given-names>T</given-names>
						</name>
						<name name-style="western">
							<surname>Dezawa</surname>
							<given-names>M</given-names>
						</name>
						<name name-style="western">
							<surname>Yusa</surname>
							<given-names>S</given-names>
						</name>
						<name name-style="western">
							<surname>Iitsuka</surname>
							<given-names>Y</given-names>
						</name>
						<etal/>
					</person-group>
					<year>1997</year>
					<article-title>A novel pathogenesis of megacolon in Ncx/Hox11L.1 deficient
						mice.</article-title>
					<source>J Clin Invest</source>
					<volume>100</volume>
					<fpage>795</fpage>
					<lpage>801</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b022">
				<label>22</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Bucher</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<year>1990</year>
					<article-title>Weight matrix descriptions of four eukaryotic RNA polymerase II
						promoter elements derived from 502 unrelated promoter
						sequences.</article-title>
					<source>J Mol Biol</source>
					<volume>212</volume>
					<fpage>563</fpage>
					<lpage>578</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b023">
				<label>23</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Burke</surname>
							<given-names>TW</given-names>
						</name>
						<name name-style="western">
							<surname>Kadonaga</surname>
							<given-names>JT</given-names>
						</name>
					</person-group>
					<year>1996</year>
					<article-title><italic>Drosophila</italic> TFIID binds to a conserved downstream
						basal promoter element that is present in many TATA-box-deficient
						promoters.</article-title>
					<source>Genes Dev</source>
					<volume>10</volume>
					<fpage>711</fpage>
					<lpage>724</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b024">
				<label>24</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Burke</surname>
							<given-names>TW</given-names>
						</name>
						<name name-style="western">
							<surname>Kadonaga</surname>
							<given-names>JT</given-names>
						</name>
					</person-group>
					<year>1997</year>
					<article-title>The downstream core promoter element, DPE, is conserved from
							<italic>Drosophila</italic> to humans and is recognized by TAFII 60 of
							<italic>Drosophila</italic>.</article-title>
					<source>Genes Dev</source>
					<volume>11</volume>
					<fpage>3020</fpage>
					<lpage>3031</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b025">
				<label>25</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Kutach</surname>
							<given-names>AK</given-names>
						</name>
						<name name-style="western">
							<surname>Kadonaga</surname>
							<given-names>JT</given-names>
						</name>
					</person-group>
					<year>2000</year>
					<article-title>The downstream promoter element DPE appears to be as widely used
						as the TATA box in <italic>Drosophila</italic> core
						promoters.</article-title>
					<source>Mol Cell Biol</source>
					<volume>20</volume>
					<fpage>4754</fpage>
					<lpage>4764</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b026">
				<label>26</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Willy</surname>
							<given-names>PJ</given-names>
						</name>
						<name name-style="western">
							<surname>Kobayashi</surname>
							<given-names>R</given-names>
						</name>
						<name name-style="western">
							<surname>Kadonaga</surname>
							<given-names>JT</given-names>
						</name>
					</person-group>
					<year>2000</year>
					<article-title>A basal transcription factor that activates or represses
						transcription.</article-title>
					<source>Science</source>
					<volume>290</volume>
					<fpage>982</fpage>
					<lpage>984</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b027">
				<label>27</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Lagrange</surname>
							<given-names>T</given-names>
						</name>
						<name name-style="western">
							<surname>Kapanidis</surname>
							<given-names>AN</given-names>
						</name>
						<name name-style="western">
							<surname>Tang</surname>
							<given-names>H</given-names>
						</name>
						<name name-style="western">
							<surname>Reinberg</surname>
							<given-names>D</given-names>
						</name>
						<name name-style="western">
							<surname>Ebright</surname>
							<given-names>RH</given-names>
						</name>
					</person-group>
					<year>1998</year>
					<article-title>New core promoter element in RNA polymerase II-dependent
						transcription: Sequence-specific DNA binding by transcription factor
						IIB.</article-title>
					<source>Genes Dev</source>
					<volume>12</volume>
					<fpage>34</fpage>
					<lpage>44</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b028">
				<label>28</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Lim</surname>
							<given-names>CY</given-names>
						</name>
						<name name-style="western">
							<surname>Santoso</surname>
							<given-names>B</given-names>
						</name>
						<name name-style="western">
							<surname>Boulay</surname>
							<given-names>T</given-names>
						</name>
						<name name-style="western">
							<surname>Dong</surname>
							<given-names>E</given-names>
						</name>
						<name name-style="western">
							<surname>Ohler</surname>
							<given-names>U</given-names>
						</name>
						<etal/>
					</person-group>
					<year>2004</year>
					<article-title>The MTE, a new core promoter element for transcription by RNA
						polymerase II.</article-title>
					<source>Genes Dev</source>
					<volume>18</volume>
					<fpage>1606</fpage>
					<lpage>1617</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b029">
				<label>29</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Lewis</surname>
							<given-names>BA</given-names>
						</name>
						<name name-style="western">
							<surname>Kim</surname>
							<given-names>TK</given-names>
						</name>
						<name name-style="western">
							<surname>Orkin</surname>
							<given-names>SH</given-names>
						</name>
					</person-group>
					<year>2000</year>
					<article-title>A downstream element in the human beta-globin promoter: Evidence
						of extended sequence-specific transcription factor IID
						contacts.</article-title>
					<source>Proc Natl Acad Sci U S A</source>
					<volume>97</volume>
					<fpage>7172</fpage>
					<lpage>7177</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b030">
				<label>30</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Lee</surname>
							<given-names>DH</given-names>
						</name>
						<name name-style="western">
							<surname>Gershenzon</surname>
							<given-names>N</given-names>
						</name>
						<name name-style="western">
							<surname>Gupta</surname>
							<given-names>M</given-names>
						</name>
						<name name-style="western">
							<surname>Ioshikhes</surname>
							<given-names>IP</given-names>
						</name>
						<name name-style="western">
							<surname>Reinberg</surname>
							<given-names>D</given-names>
						</name>
						<etal/>
					</person-group>
					<year>2005</year>
					<article-title>Functional characterization of core promoter elements: The
						downstream core element is recognized by TAF1.</article-title>
					<source>Mol Cell Biol</source>
					<volume>25</volume>
					<fpage>9674</fpage>
					<lpage>9686</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b031">
				<label>31</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Matys</surname>
							<given-names>V</given-names>
						</name>
						<name name-style="western">
							<surname>Fricke</surname>
							<given-names>E</given-names>
						</name>
						<name name-style="western">
							<surname>Geffers</surname>
							<given-names>R</given-names>
						</name>
						<name name-style="western">
							<surname>Gossling</surname>
							<given-names>E</given-names>
						</name>
						<name name-style="western">
							<surname>Haubrock</surname>
							<given-names>M</given-names>
						</name>
						<etal/>
					</person-group>
					<year>2003</year>
					<article-title>TRANSFAC: Transcriptional regulation, from patterns to
						profiles.</article-title>
					<source>Nucleic Acids Res</source>
					<volume>31</volume>
					<fpage>374</fpage>
					<lpage>378</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b032">
				<label>32</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Kel</surname>
							<given-names>AE</given-names>
						</name>
						<name name-style="western">
							<surname>Gossling</surname>
							<given-names>E</given-names>
						</name>
						<name name-style="western">
							<surname>Reuter</surname>
							<given-names>I</given-names>
						</name>
						<name name-style="western">
							<surname>Cheremushkin</surname>
							<given-names>E</given-names>
						</name>
						<name name-style="western">
							<surname>Kel-Margoulis</surname>
							<given-names>OV</given-names>
						</name>
						<etal/>
					</person-group>
					<year>2003</year>
					<article-title>MATCH: A tool for searching transcription factor binding sites in
						DNA sequences.</article-title>
					<source>Nucleic Acids Res</source>
					<volume>31</volume>
					<fpage>3576</fpage>
					<lpage>3579</lpage>
				</element-citation>
			</ref>
			<ref id="pgen-0020054-b033">
				<label>33</label>
				<element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author">
						<name name-style="western">
							<surname>Bajic</surname>
							<given-names>VB</given-names>
						</name>
						<name name-style="western">
							<surname>Seah</surname>
							<given-names>SH</given-names>
						</name>
						<name name-style="western">
							<surname>Chong</surname>
							<given-names>A</given-names>
						</name>
						<name name-style="western">
							<surname>Krishnan</surname>
							<given-names>SP</given-names>
						</name>
						<name name-style="western">
							<surname>Koh</surname>
							<given-names>JL</given-names>
						</name>
						<etal/>
					</person-group>
					<year>2003</year>
					<article-title>Computer model for recognition of functional transcription start
						sites in RNA polymerase II promoters of vertebrates.</article-title>
					<source>J Mol Graph Model</source>
					<volume>21</volume>
					<fpage>323</fpage>
					<lpage>332</lpage>
				</element-citation>
			</ref>
		</ref-list>
	</back>
</article>